References A-G



AARON, S. D., TAN, W. C., BOURBEAU, J., SIN, D. D., LOVES, R. H., MACNEIL, J. & WHITMORE, G. A. 2017. Diagnostic Instability and Reversals of Chronic Obstructive Pulmonary Disease Diagnosis in Individuals with Mild to Moderate Airflow Obstruction. Am J Respir Crit Care Med, 196, 306-314.
ABDALLAH, S. J., WILKINSON-MAITLAND, C., SAAD, N., LI, P. Z., SMITH, B. M., BOURBEAU, J. & JENSEN, D. 2017. Effect of morphine on breathlessness and exercise endurance in advanced COPD: a randomised crossover trial. Eur Respir J, 50.
ABERNETHY, A. P., CURROW, D. C., FRITH, P., FAZEKAS, B. S., MCHUGH, A. & BUI, C. 2003. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ, 327, 523-8.
ABERNETHY, A. P., MCDONALD, C. F., FRITH, P. A., CLARK, K., HERNDON, J. E., 2ND, MARCELLO, J., YOUNG, I. H., BULL, J., WILCOCK, A., BOOTH, S., WHEELER, J. L., TULSKY, J. A., CROCKETT, A. J. & CURROW, D. C. 2010. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet, 376, 784-93.
ABOUMATAR, H., GARCIA MORALES, E. E., JAGER, L. R., NAQIBUDDIN, M., KIM, S., SAUNDERS, J., BONE, L., LINNELL, J., MCBURNEY, M., NEIMAN, J., RILEY, M., ROBINSON, N., RAND, C. & WISE, R. 2022. Comparing Self-Management Programs with and without Peer Support among Patients with Chronic Obstructive Pulmonary Disease: A Clinical Trial. Ann Am Thorac Soc, 19, 1687-1696.
ABOUMATAR, H., NAQIBUDDIN, M., CHUNG, S., CHAUDHRY, H., KIM, S. W., SAUNDERS, J., BONE, L., GURSES, A. P., KNOWLTON, A., PRONOVOST, P., PUTCHA, N., RAND, C., ROTER, D., SYLVESTER, C., THOMPSON, C., WOLFF, J. L., HIBBARD, J. & WISE, R. A. 2019. Effect of a Hospital-Initiated Program Combining Transitional Care and Long-term Self-management Support on Outcomes of Patients Hospitalized With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial. Jama, 322, 1371-1380.
ABRAMSON, M. J., SCHATTNER, R. L., SULAIMAN, N. D., DEL COLLE, E. A., ARONI, R. & THIEN, F. 2012. Accuracy of asthma and COPD diagnosis in Australian general practice: a mixed methods study. Prim Care Respir J, 21, 167-73.
ABUSAID, G. H., BARBAGELATA, A., TUERO, E., MAHMOOD, A. & SHARMA, G. 2009. Diastolic dysfunction and COPD exacerbation. Postgrad Med, 121, 76-81.
ACCESS ECONOMICS PTY LIMITED FOR THE AUSTRALIAN LUNG FOUNDATION. 2008. Economic impact of COPD and cost-effective solutions.
ADABAG, A. S., WASSIF, H. S., RICE, K., MITHANI, S., JOHNSON, D., BONAWITZ-CONLIN, J., WARD, H. B., MCFALLS, E. O., KUSKOWSKI, M. A. & KELLY, R. F. 2010. Preoperative pulmonary function and mortality after cardiac surgery. Am Heart J, 159, 691-7.
ADAMS, S. G., SMITH, P. K., ALLAN, P. F., ANZUETO, A., PUGH, J. A. & CORNELL, J. E. 2007. Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management. Arch Intern Med, 167, 551-61.
ADAMSON, P. D., ANDERSON, J. A., BROOK, R. D., CALVERLEY, P. M. A., CELLI, B. R., COWANS, N. J., CRIM, C., DIXON, I. J., MARTINEZ, F. J., NEWBY, D. E., VESTBO, J., YATES, J. C. & MILLS, N. L. 2018. Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease. J Am Coll Cardiol, 72, 1126-1137.
AFZAL, S., LANGE, P., BOJESEN, S. E., FREIBERG, J. J. & NORDESTGAARD, B. G. 2014. Plasma 25-hydroxyvitamin D, lung function and risk of chronic obstructive pulmonary disease. Thorax, 69, 24-31.
AGARWAL, S. K., HEISS, G., BARR, R. G., CHANG, P. P., LOEHR, L. R., CHAMBLESS, L. E., SHAHAR, E., KITZMAN, D. W. & ROSAMOND, W. D. 2012. Airflow obstruction, lung function, and risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) study. Eur J Heart Fail, 14, 414-22.
AGLER, A. H., KURTH, T., GAZIANO, J. M., BURING, J. E. & CASSANO 2011. Randomised vitamin E supplementation and risk of chronic lung disease in the Women’s Health Study. Thorax, 66, 320-5.
AGUSTI, A., BAFADHEL, M., BEASLEY, R., BEL, E. H., FANER, R., GIBSON, P. G., LOUIS, R., MCDONALD, V. M., STERK, P. J., THOMAS, M., VOGELMEIER, C., PAVORD, I. D. & ON BEHALF OF ALL PARTICIPANTS IN THE, S. 2017. Precision medicine in airway diseases: moving to clinical practice. Eur Respir J, 50.
AGUSTI, A., BEL, E., THOMAS, M., VOGELMEIER, C., BRUSSELLE, G., HOLGATE, S., HUMBERT, M., JONES, P., GIBSON, P. G., VESTBO, J., BEASLEY, R. & PAVORD, I. D. 2016. Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J, 47, 410-9.
AGUSTI, A., CALVERLEY, P. M., CELLI, B., COXSON, H. O., EDWARDS, L. D., LOMAS, D. A., MACNEE, W., MILLER, B. E., RENNARD, S., SILVERMAN, E. K., TAL-SINGER, R., WOUTERS, E., YATES, J. C., VESTBO, J. & EVALUATION OF, C. L. T. I. P. S. E. I. 2010. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res, 11, 122.
AGUSTI, A., DE TERESA, L., DE BACKER, W., ZVARICH, M. T., LOCANTORE, N., BARNES, N., BOURBEAU, J. & CRIM, C. 2014. A comparison of the efficacy and safety of once-daily fluticasone furoate/vilanterol with twice-daily fluticasone propionate/salmeterol in moderate to very severe COPD. Eur Respir J, 43, 763-72.
AHMADI, Z., BERNELID, E., CURROW, D. C. & EKSTROM, M. 2016. Prescription of opioids for breathlessness in end-stage COPD: a national population-based study. Int J Chron Obstruct Pulmon Dis, 11, 2651-2657.
AHMEDZAI, S., BALFOUR-LYNN, I. M., BEWICK, T., BUCHDAHL, R., COKER, R. K., CUMMIN, A. R., GRADWELL, D. P., HOWARD, L., INNES, J. A., JOHNSON, A. O., LIM, E., LIM, W. S., MCKINLAY, K. P., PARTRIDGE, M. R., POPPLESTONE, M., POZNIAK, A., ROBSON, A., SHOVLIN, C. L., SHRIKRISHNA, D., SIMONDS, A., TAIT, P. & THOMAS, M. 2011. Managing passengers with stable respiratory disease planning air travel: British Thoracic Society recommendations. Thorax, 66 Suppl 1, i1-30
AKNER, G. & LARSSON, K. 2016. Undernutrition state in patients with chronic obstructive pulmonary disease. A critical appraisal on diagnostics and treatment. Respir Med, 117, 81-91
AL-GHIMLAS, F. & TODD, D. C. 2010. Creatine supplementation for patients with COPD receiving pulmonary rehabilitation: a systematic review and meta-analysis. Respirology, 15, 785-95.
ALEVA, F. E., VOETS, L. W. L. M., SIMONS, S. O., DE MAST, Q., VAN DER VEN, A. J. A. M. & HEIJDRA, Y. F. 2017. Prevalence and Localization of Pulmonary Embolism in Unexplained Acute Exacerbations of COPD: A Systematic Review and Meta-analysis. Chest, 151, 544-554.
ALEXOPOULOS, G. S., SIREY, J. A., BANERJEE, S., KIOSSES, D. N., POLLARI, C., NOVITCH, R. S., ARTIS, A. & RAUE, P. J. 2016. Two Behavioral Interventions for Patients with Major Depression and Severe COPD. Am J Geriatr Psychiatry, 24, 964-974.
ALGHAMDI, S. M., ALSULAYYIM, A. S., ALASMARI, A. M., PHILIP, K. E. J., BUTTERY, S. C., BANYA, W. A. S., POLKEY, M. I., BIRRING, S. S. & HOPKINSON, N. S. 2022. Oscillatory positive expiratory pressure therapy in COPD (O-COPD): a randomised controlled trial. Thorax, 78, 136-143.
ALHABEEB, F. F., WHITMORE, G. A., VANDEMHEEN, K. L., FITZGERALD, J. M., BERGERON, C., LEMIÈRE, C., BOULET, L. P., FIELD, S. K., PENZ, E., MCIVOR, R. A., GUPTA, S., MAYERS, I., BHUTANI, M., HERNANDEZ, P., LOUGHEED, D., LICSKAI, C. J., AZHER, T., COTE, A., AINSLIE, M., FRASER, I., MAHDAVIAN, M. & AARON, S. D. 2022. Disease burden in individuals with symptomatic undiagnosed asthma or COPD. Respir Med, 200, 106917. 
ALI,  K.  M.  2022.  Childhood asthma  as  a  risk  factor  for  adult  chronic  obstructive  pulmonary  disease:  a systematic review and meta-analysis. Expert Rev Respir Med,16,461-467.
ALISON, J. A., MCKEOUGH, Z. J., JOHNSTON, K., MCNAMARA, R. J., SPENCER, L. M., JENKINS, S. C., HILL, C. J., MCDONALD, V. M., FRITH, P., CAFARELLA, P., BROOKE, M., CAMERON-TUCKER, H. L., CANDY, S., CECINS, N., CHAN, A. S., DALE, M. T., DOWMAN, L. M., GRANGER, C., HALLORAN, S., JUNG, P., LEE, A. L., LEUNG, R., MATULICK, T., OSADNIK, C., ROBERTS, M., WALSH, J., WOOTTON, S., HOLLAND, A. E., LUNG FOUNDATION, A., THE THORACIC SOCIETY OF, A. & NEW, Z. 2017. Australian and New Zealand Pulmonary Rehabilitation Guidelines. Respirology, 22, 800-819.
ALISON, J. A., MCKEOUGH, Z. J., LEUNG, R. W. M., HOLLAND, A. E., HILL, K., MORRIS, N. R., JENKINS, S., SPENCER, L. M., HILL, C. J., LEE, A. L., SEALE, H., CECINS, N. & MCDONALD, C. F. 2019. Oxygen compared to air during exercise training in COPD with exercise-induced desaturation. Eur Respir J, 53.
ALLINSON, J. P., VLIES, B. H., BRILL, S. E., LAW, M., BURNSIDE, G., FINNEY, L. J., ALVES-MOREIRA, L., DONALDSON, G. C., CALVERLEY, P. M. A., WALKER, P. P. & WEDZICHA, J. A. 2023. A Double-Blind, Randomised, Placebo-controlled Trial of Long-Term Doxycycline Therapy on Exacerbation Rate in Patients with Stable COPD. Am J Respir Crit Care Med.
ALMAGRO, P., CABRERA, F. J., DIEZ, J., BOIXEDA, R., ALONSO ORTIZ, M. B., MURIO, C., SORIANO, J. B. & WORKING GROUP ON COPD, S. S. O. I. M. 2012. Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study. Chest, 142, 1126-33.
ALMAGRO, P., SALVADO, M., GARCIA-VIDAL, C., RODRIGUEZ-CARBALLEIRA, M., DELGADO, M., BARREIRO, B., HEREDIA, J. L. & SORIANO, J. B. 2010. Recent improvement in long-term survival after a COPD hospitalisation. Thorax, 65, 298-302.
ALSHABANAT, A., ZAFARI, Z., ALBANYAN, O., DAIRI, M. & FITZGERALD, J. M. 2015. Asthma and COPD Overlap Syndrome (ACOS): A Systematic Review and Meta Analysis. PLoS One, 10, e0136065.
ALTENBURG, W. A., DE GREEF, M. H., TEN HACKEN, N. H. & WEMPE, J. B. 2012. A better response in exercise capacity after pulmonary rehabilitation in more severe COPD patients. Respir Med, 106, 694-700.
AMEER, F., CARSON, K. V., USMANI, Z. A. & SMITH, B. J. 2014. Ambulatory oxygen for people with chronic obstructive pulmonary disease who are not hypoxaemic at rest. Cochrane Database Syst Rev, 6, CD000238.
AMERICAN PSYCHIATRIC ASSOCIATION. 2004. Diagnostic and Statistical Manual of Mental Disorders (DSM IV), American Psychiatric Association.
AMERICAN THORACIC SOCIETY. 1995. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med, 152, S77-121.
AMMOUS, O., FEKI, W., LOTFI, T., KHAMIS, A. M., GOSSELINK, R., REBAI, A. & KAMMOUN, S. 2023. Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev, 1, Cd013778.
ANDELL, P., KOUL, S., MARTINSSON, A., SUNDSTROM, J., JERNBERG, T., SMITH, J. G., JAMES, S., LINDAHL, B. & ERLINGE, D. 2014. Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction. Open Heart, 1, e000002.
ANDERSON, J., HOANG, T., HAY, K. & TAY, G. 2020. Evaluation of inpatient oxygen therapy in hypercapnic chronic obstructive pulmonary disease (COPD). Intern Med J.
ANDREWS, J., GUYATT, G., OXMAN, A. D., ALDERSON, P., DAHM, P., FALCK-YTTER, Y., NASSER, M., MEERPOHL, J., POST, P. N., KUNZ, R., BROZEK, J., VIST, G., RIND, D., AKL, E. A. & SCHUNEMANN, H. J. 2013. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol, 66, 719-25.
ANSARI, Z., DUNT, D. & DHARMAGE, S. C. 2007. Variations in hospitalizations for chronic obstructive pulmonary disease in rural and urban Victoria, Australia. Respirology, 12, 874-80.
ANTHENELLI, R. M., MORRIS, C., RAMEY, T. S., DUBRAVA, S. J., TSILKOS, K., RUSS, C. & YUNIS, C. 2013. Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial. Ann Intern Med, 159, 390-400.
ANTHONISEN, N. R., CONNETT, J. E. & MURRAY, R. P. 2002. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med, 166, 675-9.
APOSTOLO, J., COOKE, R., BOBROWICZ-CAMPOS, E., SANTANA, S., MARCUCCI, M., CANO, A., VOLLENBROEK-HUTTEN, M., GERMINI, F., D’AVANZO, B., GWYTHER, H. & HOLLAND, C. 2018. Effectiveness of interventions to prevent pre-frailty and frailty progression in older adults: a systematic review. JBI Database System Rev Implement Rep, 16, 140-232.
APPLETON, S., JONES, T., POOLE, P., PILOTTO, L., ADAMS, R., LASSERSON, T. J., SMITH, B. & MUHAMMAD, J. 2006. Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 3, CD006101.
ARANBURU-IMATZ, A., LÓPEZ-CARRASCO, J. C., MORENO-LUQUE, A., JIMÉNEZ-PASTOR, J. M., VALVERDE-LEÓN, M. D. R., RODRÍGUEZ-CORTÉS, F. J., ARÉVALO-BUITRAGO, P., LÓPEZ-SOTO, P. J. & MORALES-CANÉ, I. 2022. Nurse-Led Interventions in Chronic Obstructive Pulmonary Disease Patients: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health, 19.
ARBILLAGA-ETXARRI, A., GIMENO-SANTOS, E., BARBERAN-GARCIA, A., BALCELLS, E., BENET, M., BORRELL, E., CELORRIO, N., DELGADO, A., JANE, C., MARIN, A., MARTIN-CANTERA, C., MONTEAGUDO, M., MONTELLA, N., MUNOZ, L., ORTEGA, P., RODRIGUEZ, D. A., RODRIGUEZ-ROISIN, R., SIMONET, P., TORAN-MONSERRAT, P., TORRENT-PALLICER, J., VALL-CASAS, P., VILARO, J. & GARCIA-AYMERICH, J. 2018. Long-term efficacy and effectiveness of a behavioural and community-based exercise intervention (Urban Training) to increase physical activity in patients with COPD: a randomised controlled trial. Eur Respir J, 52.
ARCHER, S. L., MIKE, D., CROW, J., LONG, W. & WEIR, E. K. 1996. A placebo-controlled trial of prostacyclin in acute respiratory failure in COPD. Chest, 109, 750-5.
ARYAL, S., DIAZ-GUZMAN, E. & MANNINO, D. M. 2014. Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes. Int J Chron Obstruct Pulmon Dis, 9, 1145-1154.
ASH, S. Y., HARMOUCHE, R., ROSS, J. C., DIAZ, A. A., RAHAGHI, F. N., VEGAS SANCHEZ-FERRERO, G., PUTMAN, R. K., HUNNINGHAKE, G. M., ONIEVA ONIEVA, J., MARTINEZ, F. J., CHOI, A. M., BOWLER, R. P., LYNCH, D. A., HATABU, H., BHATT, S. P., DRANSFIELD, M. T., WELLS, J. M., ROSAS, I. O., SAN JOSE ESTEPAR, R. & WASHKO, G. R. 2018. Interstitial Features at Chest CT Enhance the Deleterious Effects of Emphysema in the COPDGene Cohort. Radiology, 288, 600-609.
ATLANTIS, E., FAHEY, P., COCHRANE, B., WITTERT, G. & SMITH, S. 2013. Endogenous testosterone level and testosterone supplementation therapy in chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. BMJ Open, 3.
ATTAWAY, A. H., HATIPOGLU, U., MURTHY, S. & ZEIN, J. 2019. Lung Volume Reduction Surgery in the United States From 2007 to 2013: Increasing Volumes and Reason for Caution. Chest, 155, 1080-1081.
ATWOOD, C. E., BHUTANI, M., OSPINA, M. B., ROWE, B. H., LEIGH, R., DEUCHAR, L., FARIS, P., MICHAS, M., MRKLAS, K. J., GRAHAM, J., ACERON, R., DAMANT, R., GREEN, L., HIRANI, N., LONGARD, K., MEYER, V.,  MITCHELL,  P.,  TSAI,  W.,  WALKER,  B.  &  STICKLAND,  M.  K.  2022.  Optimizing  COPD  Acute  Care Patient Outcomes Using a Standardized Transition Bundle and Care Coordinator: A Randomized Clinical Trial. Chest, 162, 321-330.
AUBIN, H. J., BOBAK, A., BRITTON, J. R., ONCKEN, C., BILLING, C. B., JR., GONG, J., WILLIAMS, K. E. & REEVES, K. R. 2008. Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial. Thorax, 63, 717-24.
AUSTIN, M. A., WILLS, K. E., BLIZZARD, L., WALTERS, E. H. & WOOD-BAKER, R. 2010. Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial. BMJ, 341, c5462.
AUSTRALIAN BUREAU OF STATISTICS. 2012. Australian Health Survey: First Results, 2011-12
AUSTRALIAN INSTITUTE OF HEALTH AND WELFARE. 2008. Australia’s Health: : The eleventh biennial health report of the Australian Institute of Health and Welfare. 11th ed. Canberra, Australian Institute of Health and Welfare.
AUSTRALIAN INSTITUTE OF HEALTH AND WELFARE & CANCER AUSTRALIA. 2011. Lung cancer in Australia: an overview. Cancer series no. 64. Cat. no. CAN 58. Canberra: AIHW.
AUSTRALIAN INSTITUTE FOR HEALTH AND WELFARE 2019. Admitted patient care 2017–18: Australian hospital statistics. 90 ed. Canberra: AIHW.
AUSTRALIAN INSTITUTE FOR HEALTH AND WELFARE 2020. Chronic obstructive pulmonary disease (COPD). Canberra: AIHW.
AUSTRALIAN INSTITUTE OF HEALTH AND WELFARE & NATIONAL INDIGENOUS AUSTRALIANS AGENCY 2020. Aboriginal and Torres Strait Islander Health Performance Framework: Measure 1.04 Respiratory Disease [Online]. Canberra: AIHW. [Accessed March 2021].
BADGETT, R. G., TANAKA, D. J., HUNT, D. K., JELLEY, M. J., FEINBERG, L. E., STEINER, J. F. & PETTY, T. L. 1993. Can moderate chronic obstructive pulmonary disease be diagnosed by historical and physical findings alone? Am J Med, 94, 188-96.
BAFADHEL, M., CRINER, G., DRANSFIELD, M. T., JANSSENS, W., MCDONALD, V. M., VOGELMEIER, C. F., RUSSELL, R. E. & COLLIS, P. 2020. Exacerbations of chronic obstructive pulmonary disease: time to rename. Lancet Respir Med, 8, 133-135.
BAFADHEL, M., DAVIES, L., CALVERLEY, P. M., AARON, S. D., BRIGHTLING, C. E. & PAVORD, I. D. 2014. Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis. Eur Respir J, 44, 789-91.
BAFADHEL, M., MCKENNA, S., TERRY, S., MISTRY, V., PANCHOLI, M., VENGE, P., LOMAS, D. A., BARER, M. R., JOHNSTON, S. L., PAVORD, I. D. & BRIGHTLING, C. E. 2012. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med, 186, 48-55.
BAFADHEL, M., PETERSON, S., DE BLAS, M. A., CALVERLEY, P. M., RENNARD, S. I., RICHTER, K. & FAGERAS, M. 2018. Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials. Lancet Respir Med, 6, 117-126.
BAGGE, K., SIVAPALAN, P., EKLÖF, J., HERTZ, F. B., ANDERSEN, C., HANSEN, E. F., JARLØV, J. O. & JENSEN, J. S. 2021. Antibiotic treatment in acute exacerbation of COPD: patient outcomes with amoxicillin vs. amoxicillin/clavulanic acid-data from 43,636 outpatients. Respir Res, 22, 11.
BAHTOUEE, M., MALEKI, N. & NEKOUEE, F. 2018. The prevalence of chronic obstructive pulmonary disease in hookah smokers. Chron Respir Dis, 15, 165-172.
BAIRD, C., LOVELL, J., JOHNSON, M., SHIELL, K. & IBRAHIM, J. E. 2017. The impact of cognitive impairment on self-management in chronic obstructive pulmonary disease: A systematic review. Respir Med, 129, 130-139.
BALDI, S., AQUILANI, R., PINNA, G. D., POGGI, P., DE MARTINI, A. & BRUSCHI, C. 2010. Fat-free mass change after nutritional rehabilitation in weight losing COPD: role of insulin, C-reactive protein and tissue hypoxia. Int J Chron Obstruct Pulmon Dis, 5, 29-39.
BALDRICK, F. R., ELBORN, J. S., WOODSIDE, J. V., TREACY, K., BRADLEY, J. M., PATTERSON, C. C., SCHOCK, B. C., ENNIS, M., YOUNG, I. S. & MCKINLEY, M. C. 2012. Effect of fruit and vegetable intake on oxidative stress and inflammation in COPD: a randomised controlled trial. Eur Respir J, 39, 1377-84.
BANKS, E., YAZIDJOGLOU, A., BROWN, S., NGUYEN, M., MARTIN, M., BECKWITH, K., DALUWATTA, A., CAMPBELL, S., & GRACE, J. 2022. Electronic cigarettes and health outcomes: systematic review of global evidence. Report for the Australian Department of Health. Canberra: National Centre for Epidemiology and Population Health.
BARBERA, J. A., ROGER, N., ROCA, J., ROVIRA, I., HIGENBOTTAM, T. W. & RODRIGUEZ-ROISIN, R. 1996. Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease. Lancet, 347, 436-40.
BARDSLEY, G., PILCHER, J., MCKINSTRY, S., SHIRTCLIFFE, P., BERRY, J., FINGLETON, J., WEATHERALL, M. & BEASLEY, R. 2018. Oxygen versus air-driven nebulisers for exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial. BMC Pulm Med, 18, 157.
BARNES, H., MCDONALD, J., SMALLWOOD, N. & MANSER, R. 2016. Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness. Cochrane Database Syst Rev, 3, CD011008.
BARNES, P. J. & CELLI, B. R. 2009. Systemic manifestations and comorbidities of COPD. Eur Respir J, 33, 1165-85.
BAROI, S., MCNAMARA, R. J., MCKENZIE, D. K., GANDEVIA, S. & BRODIE, M. A. 2018. Advances in Remote Respiratory Assessments for People with Chronic Obstructive Pulmonary Disease: A Systematic Review. Telemed J E Health, 24, 415-424.
BARR, R. G., BLUEMKE, D. A., AHMED, F. S., CARR, J. J., ENRIGHT, P. L., HOFFMAN, E. A., JIANG, R., KAWUT, S. M., KRONMAL, R. A., LIMA, J. A., SHAHAR, E., SMITH, L. J. & WATSON, K. E. 2010. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med, 362, 217-27.
BARR, R. G., BOURBEAU, J., CAMARGO, C. A. & RAM, F. S. 2005. Tiotropium for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD002876.
BARTLETT, Y. K., SHEERAN, P. & HAWLEY, M. S. 2014. Effective behaviour change techniques in smoking cessation interventions for people with chronic obstructive pulmonary disease: a meta-analysis. Br J Health Psychol, 19, 181-203.
BATEMAN, E. D., CHAPMAN, K. R., SINGH, D., D’URZO, A. D., MOLINS, E., LESELBAUM, A. & GIL, E. G. 2015. Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT). Respir Res, 16, 92.
BATEMAN, E. D., FERGUSON, G. T., BARNES, N., GALLAGHER, N., GREEN, Y., HENLEY, M. & BANERJI, D. 2013. Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study. Eur Respir J, 42, 1484-94.
BEASLEY, R., CHIEN, J., DOUGLAS, J., EASTLAKE, L., FARAH, C., KING, G., MOORE, R., PILCHER, J., RICHARDS, M., SMITH, S. & WALTERS, H. 2015. Thoracic Society of Australia and New Zealand oxygen guidelines for acute oxygen use in adults: ‘Swimming between the flags’. Respirology, 20, 1182-91.
BEAUCHAMP, M. K., HILL, K., GOLDSTEIN, R. S., JANAUDIS-FERREIRA, T. & BROOKS, D. 2009. Impairments in balance discriminate fallers from non-fallers in COPD. Respir Med, 103, 1885-91.
BEAUCHAMP, M. K., JANAUDIS-FERREIRA, T., PARREIRA, V., ROMANO, J. M., WOON, L., GOLDSTEIN, R. S. & BROOKS, D. 2013. A randomized controlled trial of balance training during pulmonary rehabilitation for individuals with COPD. Chest, 144, 1803-10.
BEAUCHAMP, M. K., SIBLEY, K. M., LAKHANI, B., ROMANO, J., MATHUR, S., GOLDSTEIN, R. S. & BROOKS, D. 2012. Impairments in systems underlying control of balance in COPD. Chest, 141, 1496-503.
BENDITT, J. O. & ALBERT, R. K. 1997. Surgical options for patients with advanced emphysema. Clin Chest Med, 18, 577-93.
BENEY, J., BERO, L. A. & BOND, C. 2000. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes. Cochrane Database Syst Rev, CD000336.
BENZO, R., FARRELL, M. H., CHANG, C. C., MARTINEZ, F. J., KAPLAN, R., REILLY, J., CRINER, G., WISE, R., MAKE, B., LUKETICH, J., FISHMAN, A. P. & SCIURBA, F. C. 2009. Integrating health status and survival data: the palliative effect of lung volume reduction surgery. Am J Respir Crit Care Med, 180, 239-46.
BENZO, R., HOULT, J., MCEVOY, C., CLARK, M., BENZO, M., JOHNSON, M. & NOVOTNY, P. 2022. Promoting COPD Wellness through Remote Monitoring and Health Coaching: A Randomized Study. Ann Am Thorac Soc, 19, 1808-1817.
BENZO, R., VICKERS, K., NOVOTNY, P. J., TUCKER, S., HOULT, J., NEUENFELDT, P., CONNETT, J., LORIG, K. & MCEVOY, C. 2016. Health Coaching and Chronic Obstructive Pulmonary Disease Rehospitalization. A Randomized Study. Am J Respir Crit Care Med, 194, 672-80.
BEREZNICKI, B., WALTERS, H., WALTERS, J., PETERSON, G. & BEREZNICKI, L. 2017. Initial diagnosis and management of chronic obstructive pulmonary disease in Australia: views from the coal face. Intern Med J, 47, 807-813.
BERNABEU-MORA, R., GARCIA-GUILLAMON, G., VALERA-NOVELLA, E., GIMENEZ-GIMENEZ, L. M., ESCOLAR-REINA, P. & MEDINA-MIRAPEIX, F. 2017. Frailty is a predictive factor of readmission within 90 days of hospitalization for acute exacerbations of chronic obstructive pulmonary disease: a longitudinal study. Ther Adv Respir Dis, 11, 383-392.
BERRY, S. D. & MILLER, R. R. 2008. Falls: epidemiology, pathophysiology, and relationship to fracture. Curr Osteoporos Rep, 6, 149-54.
BHATT, S. P., NANDA, S. & KINTZER, J. S. 2012. Arrhythmias as trigger for acute exacerbations of chronic obstructive pulmonary disease. Respir Med, 106, 1134-8.
BHATT, S. P., KIM, Y. I., WELLS, J. M., BAILEY, W. C., RAMSDELL, J. W., FOREMAN, M. G., JENSEN, R. L., STINSON, D. S., WILSON, C. G., LYNCH, D. A., MAKE, B. J. & DRANSFIELD, M. T. 2014a. FEV(1)/FEV(6) to diagnose airflow obstruction. Comparisons with computed tomography and morbidity indices. Ann Am Thorac Soc, 11, 335-41.
BHATT, S. P., SIEREN, J. C., DRANSFIELD, M. T., WASHKO, G. R., NEWELL, J. D., JR., STINSON, D. S., ZAMBA, G. K. & HOFFMAN, E. A. 2014b. Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction. Thorax, 69, 409-14.
BHATT, S. P., BALTE, P. P., SCHWARTZ, J. E., CASSANO, P. A., COUPER, D., JACOBS, D. R., JR., KALHAN, R., O’CONNOR, G. T., YENDE, S., SANDERS, J. L., UMANS, J. G., DRANSFIELD, M. T., CHAVES, P. H., WHITE, W. B. & OELSNER, E. C. 2019. Discriminative Accuracy of FEV1:FVC Thresholds for COPD-Related Hospitalization and Mortality. Jama, 321, 2438-2447.
BHATT, S. P., BLAUER-PETERSON, C., BUYSMAN, E. K., BENGTSON, L. G. S. & PAINE III, S. R. 2022. Trends and Characteristics of Global Initiative for Chronic Obstructive Lung Disease Guidelines-Discordant Prescribing of Triple Therapy Among Patients with COPD. Chronic Obstr Pulm Dis, 9(2), 135–153.
BHATT, S. P., RABE, K. F., HANANIA, N. A., VOGELMEIER, C. F., COLE, J., BAFADHEL, M., CHRISTENSON, S. A., PAPI, A., SINGH, D., LAWS, E., MANNENT, L. P., PATEL, N., STAUDINGER, H. W., YANCOPOULOS, G. D., MORTENSEN, E. R., AKINLADE, B., MALONEY, J., LU, X., BAUER, D., BANSAL, A., ROBINSON, L. B. & ABDULAI, R. M. 2023. Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts. N Engl J Med, 389, 205-214.
BHATTARAI, B., WALPOLA, R., MEY, A., ANOOPKUMAR-DUKIE, S. & KHAN, S. 2020. Barriers and Strategies for Improving Medication Adherence Among People Living With COPD: A Systematic Review. Respir Care, 65, 1738-1750.
BIANCARDI, E., FENNELL, M., RAWLINSON, W. & THOMAS, P. S. 2016. Viruses are frequently present as the infecting agent in acute exacerbations of chronic obstructive pulmonary disease in patients presenting to hospital. Intern Med J, 46, 1160-1165.
BIERUT, L. J. 2010. Convergence of genetic findings for nicotine dependence and smoking related diseases with chromosome 15q24-25. Trends Pharmacol Sci, 31, 46-51
BISCHOFF, E. W., AKKERMANS, R., BOURBEAU, J., VAN WEEL, C., VERCOULEN, J. H. & SCHERMER, T. R. 2012. Comprehensive self management and routine monitoring in chronic obstructive pulmonary disease patients in general practice: randomised controlled trial. BMJ, 345, e7642.
BISELLI, P. J., KIRKNESS, J. P., GROTE, L., FRICKE, K., SCHWARTZ, A. R., SMITH, P. & SCHNEIDER, H. 2017. Nasal high-flow therapy reduces work of breathing compared with oxygen during sleep in COPD and smoking controls: a prospective observational study. J Appl Physiol (1985), 122, 82-88.
BLACKSTOCK, F. & WEBSTER, K. 2007. Disease-specific health education for COPD: a systematic review of changes in health outcomes. Health Educ Res, 22, 703-17.
BLACKSTOCK, F. C., WEBSTER, K. E., MCDONALD, C. F. & HILL, C. J. 2014. Comparable improvements achieved in chronic obstructive pulmonary disease through pulmonary rehabilitation with and without a structured educational intervention: a randomized controlled trial. Respirology, 19, 193-202.
BLAKEMORE, A., DICKENS, C., GUTHRIE, E., BOWER, P., KONTOPANTELIS, E., AFZAL, C. & COVENTRY, P. A. 2014. Depression and anxiety predict health-related quality of life in chronic obstructive pulmonary disease: systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis, 9, 501-12.
BLANC, P. D., IRIBARREN, C., TRUPIN, L., EARNEST, G., KATZ, P. P., BALMES, J., SIDNEY, S. & EISNER, M. D. 2009. Occupational exposures and the risk of COPD: dusty trades revisited. Thorax, 64, 6-12.
BLANCO, I., DE SERRES, F. J., FERNANDEZ-BUSTILLO, E., LARA, B. & MIRAVITLLES, M. 2006. Estimated numbers and prevalence of PI*S and PI*Z alleles of alpha1-antitrypsin deficiency in European countries. Eur Respir J, 27, 77-84.
BLINDERMAN, C. D., HOMEL, P., BILLINGS, J. A., TENNSTEDT, S. & PORTENOY, R. K. 2009. Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease. J Pain Symptom Manage, 38, 115-23.
BOCK, K., BENDSTRUP, E., HILBERG, O. & LOKKE, A. 2017. Screening tools for evaluation of depression in Chronic Obstructive Pulmonary Disease (COPD). A systematic review. Eur Clin Respir J, 4, 1332931.
BOLTON, C. E., WATERS, C. S., PEIRCE, S. & ELWYN, G. 2011. Insufficient evidence of benefit: a systematic review of home telemonitoring for COPD. J Eval Clin Pract, 17, 1216-22.
BONTEN, M. J., HUIJTS, S. M., BOLKENBAAS, M., WEBBER, C., PATTERSON, S., GAULT, S., VAN WERKHOVEN, C. H., VAN DEURSEN, A. M., SANDERS, E. A., VERHEIJ, T. J., PATTON, M., MCDONOUGH, A., MORADOGHLI-HAFTVANI, A., SMITH, H., MELLELIEU, T., PRIDE, M. W., CROWTHER, G., SCHMOELE-THOMA, B., SCOTT, D. A., JANSEN, K. U., LOBATTO, R., OOSTERMAN, B., VISSER, N., CASPERS, E., SMORENBURG, A., EMINI, E. A., GRUBER, W. C. & GROBBEE, D. E. 2015. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med, 372, 1114-25.
BORGHI-SILVA, A., BALDISSERA, V., SAMPAIO, L. M., PIRES-DILORENZO, V. A., JAMAMI, M., DEMONTE, A., MARCHINI, J. S. & COSTA, D. 2006. L-carnitine as an ergogenic aid for patients with chronic obstructive pulmonary disease submitted to whole-body and respiratory muscle training programs. Braz J Med Biol Res, 39, 465-74.
BORRILL, Z., HOUGHTON, C., SULLIVAN, P. J. & SESTINI, P. 2003. Retrospective analysis of evidence base for tests used in diagnosis and monitoring of disease in respiratory medicine. BMJ, 327, 1136-8.
BOSNIC-ANTICEVICH, S., CHRYSTYN, H., COSTELLO, R. W., DOLOVICH, M. B., FLETCHER, M. J., LAVORINI, F., RODRIGUEZ-ROISIN, R., RYAN, D., WAN YAU MING, S. & PRICE, D. B. 2017. The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes. Int J Chron Obstruct Pulmon Dis, 12, 59-71.
BOUDESTEIN, L. C., RUTTEN, F. H., CRAMER, M. J., LAMMERS, J. W. & HOES, A. W. 2009. The impact of concurrent heart failure on prognosis in patients with chronic obstructive pulmonary disease. Eur J Heart Fail, 11, 1182-8.
BOURDIN, A., MOLINARI, N., FERGUSON, G. T., SINGH, B., SIDDIQUI, M. K., HOLMGREN, U., OUWENS, M., JENKINS, M. & DE NIGRIS, E. 2021. Efficacy and Safety of Budesonide/Glycopyrronium/Formoterol Fumarate versus Other Triple Combinations in COPD: A Systematic Literature Review and Network Meta-analysis. Adv Ther.
BOUTOU, A. K., KARRAR, S., HOPKINSON, N. S. & POLKEY, M. I. 2013. Anemia and survival in chronic obstructive pulmonary disease: a dichotomous rather than a continuous predictor. Respiration, 85, 126-31.
BOUTOU, A. K., PITSIOU, G. G., STANOPOULOS, I., KONTAKIOTIS, T., KYRIAZIS, G. & ARGYROPOULOU, P. 2012. Levels of inflammatory mediators in chronic obstructive pulmonary disease patients with anemia of chronic disease: a case-control study. QJM, 105, 657-63.
BOUTOU, A. K., STANOPOULOS, I., PITSIOU, G. G., KONTAKIOTIS, T., KYRIAZIS, G., SICHLETIDIS, L. & ARGYROPOULOU, P. 2011. Anemia of chronic disease in chronic obstructive pulmonary disease: a case-control study of cardiopulmonary exercise responses. Respiration, 82, 237-45.
BOVE, D. G., LOMBORG, K., JENSEN, A. K., OVERGAARD, D., LINDHARDT, B. O. & MIDTGAARD, J. 2016. Efficacy of a minimal home-based psychoeducative intervention in patients with advanced COPD: A randomised controlled trial. Respir Med, 121, 109-116.
BOWLER, R. P., HANSEL, N. N., JACOBSON, S., GRAHAM BARR, R., MAKE, B. J., HAN, M. K., O’NEAL, W. K., OELSNER, E. C., CASABURI, R., BARJAKTAREVIC, I., COOPER, C., FOREMAN, M., WISE, R. A., DEMEO, D. L., SILVERMAN, E. K., BAILEY, W., HARRINGTON, K. F., WOODRUFF, P. G. & DRUMMOND, M. B. 2017. Electronic Cigarette Use in US Adults at Risk for or with COPD: Analysis from Two Observational Cohorts. J Gen Intern Med, 32, 1315-1322.
BRADLEY, J. M., LASSERSON, T., ELBORN, S., MACMAHON, J. & O’NEILL, B. (2007) A systematic review of randomized controlled trials examining the short-term benefit of ambulatory oxygen in COPD. Chest, 131, 278-85.
BRADLEY, J. M. & O’NEILL, B. (2005) Short term ambulatory oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD004356.
BRAIDO, F., BAIARDINI, I., CAZZOLA, M., BRUSSELLE, G., MARUGO, F. & CANONICA, G. W. (2013) Long-acting bronchodilators improve health related quality of life in patients with COPD. Respir Med, 107, 1465-80.
BREMNER, P. R., BIRK, R., BREALEY, N., ISMAILA, A. S., ZHU, C. Q. & LIPSON, D. A. 2018. Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive pulmonary disease: a randomized non-inferiority study. Respir Res, 19, 19.
BRIGHTLING, C. E., BLEECKER, E. R., PANETTIERI, R. A., JR., BAFADHEL, M., SHE, D., WARD, C. K., XU, X., BIRRELL, C. & VAN DER MERWE, R. 2014. Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study. Lancet Respir Med, 2, 891-901.
BRITISH THORACIC SOCIETY. 2008. BTS statement on criteria for specialist referral, admission, discharge and follow-up for adults with respiratory disease. Thorax, 63 Suppl 1, i1-i16.
BROEKHUIZEN, R., WOUTERS, E. F., CREUTZBERG, E. C., WELING-SCHEEPERS, C. A. & SCHOLS, A. M. 2005. Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease. Thorax, 60, 376-82.
BROOKS, D., KRIP, B., MANGOVSKI-ALZAMORA, S. & GOLDSTEIN, R. S. 2002. The effect of postrehabilitation programmes among individuals with chronic obstructive pulmonary disease. Eur Respir J, 20, 20-9.
BROWN, C. E., ENGELBERG, R. A., NIELSEN, E. L. & CURTIS, J. R. 2016. Palliative Care for Patients Dying in the Intensive Care Unit with Chronic Lung Disease Compared with Metastatic Cancer. Ann Am Thorac Soc, 13, 684-9.
BROWNRIDGE, D. J. & ZAIDI, S. T. R. 2017. Retrospective audit of antimicrobial prescribing practices for acute exacerbations of chronic obstructive pulmonary diseases in a large regional hospital. J Clin Pharm Ther, 42, 301-305.
BRUNELLI, A., KIM, A. W., BERGER, K. I. & ADDRIZZO-HARRIS, D. J. 2013. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 143, e166S-90S.
BRUSKE, I., THIERING, E., HEINRICH, J., HUSTER, K. M. & NOWAK, D. 2014. Respirable quartz dust exposure and airway obstruction: a systematic review and meta-analysis. Occup Environ Med, 71, 583-9.
BRYANT, J., MCDONALD, V. M., BOYES, A., SANSON-FISHER, R., PAUL, C. & MELVILLE, J. 2013. Improving medication adherence in chronic obstructive pulmonary disease: a systematic review. Respir Res, 14, 109.
BUCKNALL, C. E., MILLER, G., LLOYD, S. M., CLELAND, J., MCCLUSKEY, S., COTTON, M., STEVENSON, R. D., COTTON, P. & MCCONNACHIE, A. 2012. Glasgow supported self-management trial (GSuST) for patients with moderate to severe COPD: randomised controlled trial. BMJ, 344, e1060.
BUI, D. S., LODGE, C. J., BURGESS, J. A., LOWE, A. J., PERRET, J., BUI, M. Q., BOWATTE, G., GURRIN, L., JOHNS, D. P., THOMPSON, B. R., HAMILTON, G. S., FRITH, P. A., JAMES, A. L., THOMAS, P. S., JARVIS, D., SVANES, C., RUSSELL, M., MORRISON, S. C., FEATHER, I., ALLEN, K. J., WOOD-BAKER, R., HOPPER, J., GILES, G. G., ABRAMSON, M. J., WALTERS, E. H., MATHESON, M. C. & DHARMAGE, S. C. 2018. Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life. Lancet Respir Med, 6, 535-544.
BUI, D. S., LODGE, C. J., PERRET, J. L., LOWE, A., HAMILTON, G. S., THOMPSON, B., GILES, G., TAN, D., ERBAS, B., PIRKIS, J., CICUTTINI, F., CASSIM, R., BOWATTE, G., THOMAS, P., GARCIA-AYMERICH, J., HOPPER, J., ABRAMSON, M. J., WALTERS, E. H. & DHARMAGE, S. C. 2021. Trajectories of asthma and allergies from 7 years to 53 years and associations with lung function and extrapulmonary comorbidity profiles: a prospective cohort study. Lancet Respir Med, 9, 387-396.
BUI, D. S., PERRET, J. L., WALTERS, E. H., LODGE, C. J., BOWATTE, G., HAMILTON, G. S., THOMPSON, B. R., FRITH, P., ERBAS, B., THOMAS, P. S., JOHNS, D. P., WOOD-BAKER, R., HOPPER, J. L., DAVIS, P. G., ABRAMSON, M. J., LOWE, A. J. & DHARMAGE, S. C. 2022. Association between very to moderate preterm births, lung function deficits, and COPD at age 53 years: analysis of a prospective cohort study. Lancet Respir Med. 10 (5), pp.478-484.
BULA, C. J., WIETLISBACH, V., BURNAND, B. & YERSIN, B. 2001. Depressive symptoms as a predictor of 6-month outcomes and services utilization in elderly medical inpatients. Arch Intern Med, 161, 2609-15.
BULLEN, C., HOWE, C., LAUGESEN, M., MCROBBIE, H., PARAG, V., WILLIMAN, J. & WALKER, N. 2013. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet, 382, 1629-37.
BURGE, A. T., MALAGUTI, C., HOFFMAN, M., SHIELL, A., MCDONALD, C. F., BERLOWITZ, D. J. & HOLLAND, A. E. 2022. Efficacy of Repeating Pulmonary Rehabilitation in People with COPD: A Systematic Review. Int J Chron Obstruct Pulmon Dis, 17, 1871-1882.
BURGEL, P. R., NESME-MEYER, P., CHANEZ, P., CAILLAUD, D., CARRE, P., PEREZ, T. & ROCHE, N. 2009. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest, 135, 975-82.
BURNS, K. E., MEADE, M. O., PREMJI, A. & ADHIKARI, N. K. 2013. Noninvasive positive-pressure ventilation as a weaning strategy for intubated adults with respiratory failure. Cochrane Database Syst Rev, 12, CD004127.
BURROWS, B., KNUDSON, R., CLINE, M. & LEBOWITZ, M. 1977. Quantitative relationships between cigarette smoking and ventilatory function. American Rev Respir Dis, 115, 195-205.
BURSI, F., VASSALLO, R., WESTON, S. A., KILLIAN, J. M. & ROGER, V. L. 2010. Chronic obstructive pulmonary disease after myocardial infarction in the community. Am Heart J, 160, 95-101.
BUSCH, R., HAN, M. K., BOWLER, R. P., DRANSFIELD, M. T., WELLS, J. M., REGAN, E. A. & HERSH, C. P. 2016. Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort. BMC Pulm Med, 16, 28.
BUTLER, C. C., GILLESPIE, D., WHITE, P., BATES, J., LOWE, R., THOMAS-JONES, E., WOOTTON, M., HOOD, K., PHILLIPS, R., MELBYE, H., LLOR, C., CALS, J. W. L., NAIK, G., KIRBY, N., GAL, M., RIGA, E. & FRANCIS, N. A. 2019. C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations. N Engl J Med, 381, 111-120.
BUTTERY, S. C., BANYA, W., BILANCIA, R., BOYD, E., BUCKLEY, J., GREENING, N. J., HOUSLEY, K., JORDAN, S., KEMP, S. V., KIRK, A. J. B., LATIMER, L., LAU, K., LAWSON, R., LEWIS, A., MOXHAM, J., RATHINAM, S., STEINER, M. C., TENCONI, S., WALLER, D., SHAH, P. L. & HOPKINSON, N. S. 2023. Lung volume reduction surgery versus endobronchial valves: a randomised controlled trial. Eur Respir J, 61.
CAHILL, K., STEAD, L. F. & LANCASTER, T. 2008. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev, CD006103.
CAHILL, K., STEVENS, S., PERERA, R. & LANCASTER, T. 2013. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev, 5, CD009329.
CALDERAZZO, M. A., TRUJILLO-TORRALBO, M. B., FINNEY, L. J., SINGANAYAGAM, A., BAKHSOLIANI, E., PADMANABAN, V., KEBADZE, T., ANISCENKO, J., ELKIN, S. L., JOHNSTON, S. L. & MALLIA, P. 2019. Inflammation and infections in unreported chronic obstructive pulmonary disease exacerbations. Int J Chron Obstruct Pulmon Dis, 14, 823-832.
CALLE RUBIO, M., ALCAZAR NAVARRETE, B., SORIANO, J. B., SOLER-CATALUNA, J. J., RODRIGUEZ GONZALEZ-MORO, J. M., FUENTES FERRER, M. E. & LOPEZ-CAMPOS, J. L. 2017. Clinical audit of COPD in outpatient respiratory clinics in Spain: the EPOCONSUL study. Int J Chron Obstruct Pulmon Dis, 12, 417-426.
CALVERLEY, P. M., ANDERSON, J. A., CELLI, B., FERGUSON, G. T., JENKINS, C., JONES, P. W., CRIM, C., WILLITS, L. R., YATES, J. C. & VESTBO, J. 2010. Cardiovascular events in patients with COPD: TORCH study results. Thorax, 65, 719-25.
CALVERLEY, P. M., ANDERSON, J. A., CELLI, B., FERGUSON, G. T., JENKINS, C., JONES, P. W., YATES, J. C. & VESTBO, J. 2007. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med, 356, 775-89.
CALVERLEY, P. M., STOCKLEY, R. A., SEEMUNGAL, T. A., HAGAN, G., WILLITS, L. R., RILEY, J. H. & WEDZICHA, J. A. 2011. Reported pneumonia in patients with COPD: findings from the INSPIRE study. Chest, 139, 505-12.
CALVERLEY, P. M. A., ANDERSON, J. A., BROOK, R. D., CRIM, C., GALLOT, N., KILBRIDE, S., MARTINEZ, F. J., YATES, J., NEWBY, D. E., VESTBO, J., WISE, R. & CELLI, B. R. 2018a. Fluticasone Furoate, Vilanterol, and Lung Function Decline in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk. Am J Respir Crit Care Med, 197, 47-55.
CALVERLEY, P. M. A., ANZUETO, A. R., CARTER, K., GRONKE, L., HALLMANN, C., JENKINS, C., WEDZICHA, J. & RABE, K. F. 2018b. Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial. Lancet Respir Med, 6, 337-344.
CALZETTA, L., RITONDO, B. L., DE MARCO, P., CAZZOLA, M. & ROGLIANI, P. 2020. Evaluating triple ICS/LABA/LAMA therapies for COPD patients: a network meta-analysis of ETHOS, KRONOS, IMPACT, and TRILOGY studies. Expert Rev Respir Med, 1-10.
CALZETTA, L., CAZZOLA, M., MATERA, M. G. & ROGLIANI, P. 2019. Adding a LAMA to ICS/LABA Therapy: A Meta-analysis of Triple Combination Therapy in COPD. Chest, 155, 758-770.
CAMP, P. G., COXSON, H. O., LEVY, R. D., PILLAI, S. G., ANDERSON, W., VESTBO, J., KENNEDY, S. M., SILVERMAN, E. K., LOMAS, D. A. & PARE, P. D. 2009. Sex differences in emphysema and airway disease in smokers. Chest, 136, 1480-8.
CANCER COUNCIL AUSTRALIA. 2004. Clinical Practice Guidelines for the Prevention, Diagnosis and Management of Lung Cancer. Sydney.
CANNON, D., BUYS, N., SRIRAM, K. B., SHARMA, S., MORRIS, N. & SUN, J. 2016. The effects of chronic obstructive pulmonary disease self-management interventions on improvement of quality of life in COPD patients: A meta-analysis. Respir Med, 121, 81-90.
CAPONNETTO, P., CAMPAGNA, D., CIBELLA, F., MORJARIA, J. B., CARUSO, M., RUSSO, C. & POLOSA, R. 2013. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One, 8, e66317.
CARR, A. B. & EBBERT, J. 2012. Interventions for tobacco cessation in the dental setting. Cochrane Database Syst Rev, 6, CD005084.
CARR, L. L., JACOBSON, S., LYNCH, D. A., FOREMAN, M. G., FLENAUGH, E. L., HERSH, C. P., SCIURBA, F. C., WILSON, D. O., SIEREN, J. C., MULHALL, P., KIM, V., KINSEY, C. M. & BOWLER, R. P. 2018. Features of COPD as Predictors of Lung Cancer. Chest, 153, 1326-1335.
CASANOVA, C., CELLI, B. R., DE-TORRES, J. P., MARTINEZ-GONZALEZ, C., COSIO, B. G., PINTO-PLATA, V., DE LUCAS-RAMOS, P., DIVO, M., FUSTER, A., PECES-BARBA, G., CALLE-RUBIO, M., SOLANES, I., AGUERO, R., FEU-COLLADO, N., ALFAGEME, I., DE DIEGO, A., ROMERO, A., BALCELLS, E., LLUNELL, A., GALDIZ, J. B., MARIN, M., MORENO, A., CABRERA, C., GOLPE, R., LACARCEL, C., SORIANO, J. B., LOPEZ-CAMPOS, J. L., SOLER-CATALUNA, J. J. & MARIN, J. M. 2017. Prevalence of persistent blood eosinophilia: relation to outcomes in patients with COPD. Eur Respir J, 50.
CASANOVA, C., COTE, C., DE TORRES, J. P., AGUIRRE-JAIME, A., MARIN, J. M., PINTO-PLATA, V. & CELLI, B. R. 2005. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 171, 591-7.
CASAS, A., TROOSTERS, T., GARCIA-AYMERICH, J., ROCA, J., HERNANDEZ, C., ALONSO, A., DEL POZO, F., DE TOLEDO, P., ANTO, J. M., RODRIGUEZ-ROISIN, R. & DECRAMER, M. 2006. Integrated care prevents hospitalisations for exacerbations in COPD patients. Eur Respir J, 28, 123-30.
CATES, C. J., CRILLY, J. A. & ROWE, B. H. 2006. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev, CD000052.
CAVALHERI, V., STRAKER, L., GUCCIARDI, D. F., GARDINER, P. A. & HILL, K. 2016. Changing physical activity and sedentary behaviour in people with COPD. Respirology, 21, 419-26.
CAZZOLA, M., CALZETTA, L., PAGE, C., JARDIM, J., CHUCHALIN, A. G., ROGLIANI, P. & MATERA, M. G. 2015a. Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis. Eur Respir Rev, 24, 451-61.
CAZZOLA, M., CALZETTA, L., PAGE, C., ROGLIANI, P. & MATERA, M. G. 2018a. Impact of erdosteine on chronic bronchitis and COPD: A meta-analysis. Pulm Pharmacol Ther, 48, 185-194.
CAZZOLA, M., HANANIA, N. A., MACNEE, W., RUDELL, K., HACKFORD, C. & TAMIMI, N. 2015b. A review of the most common patient-reported outcomes in COPD–revisiting current knowledge and estimating future challenges. Int J Chron Obstruct Pulmon Dis, 10, 725-38.
CAZZOLA, M., ROGLIANI, P., CALZETTA, L. & MATERA, M. G. 2018b. Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis. Eur Respir J, 52.
CECERE, L. M., LITTMAN, A. J., SLATORE, C. G., UDRIS, E. M., BRYSON, C. L., BOYKO, E. J., PIERSON, D. J. & AU, D. H. 2011. Obesity and COPD: associated symptoms, health-related quality of life, and medication use. COPD, 8, 275-84.
CELLI, B., DECRAMER, M., KESTEN, S., LIU, D., MEHRA, S. & TASHKIN, D. P. 2009. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 180, 948-55.
CELLI, B. R. 1995. Pulmonary rehabilitation in patients with COPD. Am J Respir Crit Care Med, 152, 861-4.
CELLI, B. R., COTE, C. G., LAREAU, S. C. & MEEK, P. M. 2008. Predictors of Survival in COPD: more than just the FEV1. Respir Med, 102 Suppl 1, S27-35.
CELLI, B. R., COTE, C. G., MARIN, J. M., CASANOVA, C., MONTES DE OCA, M., MENDEZ, R. A., PINTO PLATA, V. & CABRAL, H. J. 2004. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med, 350, 1005-12.
CERVERI, I., CORSICO, A. G., ACCORDINI, S., NINIANO, R., ANSALDO, E., ANTO, J. M., KUNZLI, N., JANSON, C., SUNYER, J., JARVIS, D., SVANES, C., GISLASON, T., HEINRICH, J., SCHOUTEN, J. P., WJST, M., BURNEY, P. & DE MARCO, R. 2008. Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes. Thorax, 63, 1040-5.
CHAMBELLAN, A., CHAILLEUX, E., SIMILOWSKI, T. & GROUP, A. O. 2005. Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest, 128, 1201-8.
CHANG, A. B., BELL, S. C., TORZILLO, P. J., KING, P. T., MAGUIRE, G. P., BYRNES, C. A., HOLLAND, A. E., O’MARA, P., GRIMWOOD, K. & EXTENDED VOTING, G. 2015. Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines. Med J Aust, 202, 130.
CHANG, C. L., ROBINSON, S. C., MILLS, G. D., SULLIVAN, G. D., KARALUS, N. C., MCLACHLAN, J. D. & HANCOX, R. J. 2011. Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD. Thorax, 66, 764-8.
CHAOUAT, A., BUGNET, A. S., KADAOUI, N., SCHOTT, R., ENACHE, I., DUCOLONE, A., EHRHART, M., KESSLER, R. & WEITZENBLUM, E. 2005. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 172, 189-94.
CHAOUAT, A., NAEIJE, R. & WEITZENBLUM, E. 2008. Pulmonary hypertension in COPD. Eur Respir J, 32, 1371-85.
CHAOUAT, A., WEITZENBLUM, E., KESSLER, R., CHARPENTIER, C., ENRHART, M., SCHOTT, R., LEVI-VALENSI, P., ZIELINSKI, J., DELAUNOIS, L., CORNUDELLA, R. & MOUTINHO DOS SANTOS, J. 1999. A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. Eur Respir J, 14, 1002-8.
CHAOUAT, A., WEITZENBLUM, E., KRIEGER, J., IFOUNDZA, T., OSWALD, M. & KESSLER, R. 1995. Association of chronic obstructive pulmonary disease and sleep apnea syndrome. Am J Respir Crit Care Med, 151, 82-6.
CHAPMAN, K. R., BEEH, K. M., BEIER, J., BATEMAN, E. D., D’URZO, A., NUTBROWN, R., HENLEY, M., CHEN, H., OVEREND, T. & D’ANDREA, P. 2014. A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 study. BMC Pulm Med, 14, 4.
CHAPMAN, K. R., HURST, J. R., FRENT, S. M., LARBIG, M., FOGEL, R., GUERIN, T., BANERJI, D., PATALANO, F., GOYAL, P., PFISTER, P., KOSTIKAS, K. & WEDZICHA, J. A. 2018. Long-term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in COPD Patients (SUNSET): a Randomized, Double-Blind, Triple-Dummy Clinical Trial. Am J Respir Crit Care Med, 198, 329-339.
CHAVANNES, N. H., GRIJSEN, M., VAN DEN AKKER, M., SCHEPERS, H., NIJDAM, M., TIEP, B. & MURIS, J. 2009. Integrated disease management improves one-year quality of life in primary care COPD patients: a controlled clinical trial. Prim Care Respir J, 18, 171-6.
CHEN, D., RESTREPO, M. I., FINE, M. J., PUGH, M. J., ANZUETO, A., METERSKY, M. L., NAKASHIMA, B., GOOD, C. & MORTENSEN, E. M. 2011. Observational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia. Am J Respir Crit Care Med, 184, 312-6.
CHEN, K., PLEASANTS, K. A., PLEASANTS, R. A., BEIKO, T., WASHBURN, R. G., YU, Z., ZHAI, S. & DRUMMOND, M. B. 2020. Procalcitonin for Antibiotic Prescription in Chronic Obstructive Pulmonary Disease Exacerbations: Systematic Review, Meta-Analysis, and Clinical Perspective. Pulm Ther.
CHEN, H. & WANG, K. 2022. Response. CHEST, 162, e334-e341.
CHEN, H., DENG, Z. X., SUN, J., HUANG, Q., HUANG, L., HE, Y. H., MA, C. & WANG, K. 2023. Association of Inhaled Corticosteroids With All-Cause Mortality Risk in Patients With COPD: A Meta-analysis of 60 Randomized Controlled Trials. Chest, 163, 100-114.
CHEN, P., LI, Y., WU, D., LIU, F. & CAO, C. 2023. Secondhand Smoke Exposure and the Risk of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. Int J Chron Obstruct Pulmon Dis, 18, 1067-1076.
CHEN, W. C., HUANG, C. H., SHEU, C. C., CHONG, I. W., CHU, K. A., CHEN, Y. C., TSAI, J. R., LEE, C. H. & WEI, Y. F. 2017. Long-acting beta2-agonists versus long-acting muscarinic antagonists in patients with stable COPD: A systematic review and meta-analysis of randomized controlled trials. Respirology, 22, 1313-1319.
CHEN, W., THOMAS, J., SADATSAFAVI, M. & FITZGERALD, J. M. 2015. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med, 3, 631-9.
CHEN, Y. W., RAMSOOK, A. H., COXSON, H. O., BON, J. & REID, W. D. 2019. Prevalence and Risk Factors for Osteoporosis in Individuals With COPD: A Systematic Review and Meta-analysis. Chest. 156(6), 1092-1110
CHENG, S. W. M., MCKEOUGH, Z., ALISON, J., DENNIS, S., HAMER, M. & STAMATAKIS, E. 2018. Associations of total and type-specific physical activity with mortality in chronic obstructive pulmonary disease: a population-based cohort study. BMC Public Health, 18, 268.
CHENG, S. W. M., MCKEOUGH, Z. J., MCNAMARA, R. J. & ALISON, J. A. 2023. Pulmonary Rehabilitation Using Minimal Equipment for People With Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. Phys Ther, 103.
CHEYNE, L., IRVIN-SELLERS, MJ. & WHITE, J., 2015. Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 9, CD009552.
CHONG, J., KARNER, C. & POOLE, P. 2012. Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 9, CD009157.
CHONG, J., LEUNG, B. & POOLE, P. 2017. Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 9, CD002309.
CHOW, J. W., KHULLAR, K., KATECHIA, K., KLIM, S. & KELLY, A. M. 2016. Controlled oxygen therapy at emergency department presentation increases the likelihood of achieving target oxygen saturations in patients with exacerbations of chronic obstructive pulmonary disease. Emerg Med Australas, 28, 44-7.
CHRYSTYN, H., VAN DER PALEN, J., SHARMA, R., BARNES, N., DELAFONT, B., MAHAJAN, A. & THOMAS, M. 2017. Device errors in asthma and COPD: systematic literature review and meta-analysis. NPJ Prim Care Respir Med, 27, 22.
CLEGG, A., YOUNG, J., ILIFFE, S., RIKKERT, M. O. & ROCKWOOD, K. 2013. Frailty in elderly people. Lancet, 381, 752-62.
COE, J. W., BROOKS, P. R., VETELINO, M. G., WIRTZ, M. C., ARNOLD, E. P., HUANG, J., SANDS, S. B., DAVIS, T. I., LEBEL, L. A., FOX, C. B., SHRIKHANDE, A., HEYM, J. H., SCHAEFFER, E., ROLLEMA, H., LU, Y., MANSBACH, R. S., CHAMBERS, L. K., ROVETTI, C. C., SCHULZ, D. W., TINGLEY, F. D., 3RD & O’NEILL, B. T. 2005. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. J Med Chem, 48, 3474-7.
ÇOLAK, Y., NORDESTGAARD, B. G., VESTBO, J., AFZAL, S. & LANGE, P. 2022. Potential clinical implications of targeted spirometry for detection of COPD: A contemporary population-based cohort study. Respir Med,197,106852.
COLLINS, P. F., ELIA, M., KURUKULAARATCHY, R. J. & STRATTON, R. J. 2018. The influence of deprivation on malnutrition risk in outpatients with chronic obstructive pulmonary disease (COPD). Clin Nutr. 2018;37(1), 144-48.
COLLINS, P. F., ELIA, M. & STRATTON, R. J. 2013. Nutritional support and functional capacity in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respirology, 18, 616-29.
COLLINS, P. F., STRATTON, R. J. & ELIA, M. 2012. Nutritional support in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Am J Clin Nutr, 95, 1385-95.
COMMONWEALTH OF AUSTRALIA. 2023. National Tobacco Strategy 2023-2030. Canberra.
CONNORS, A. F., JR., DAWSON, N. V., THOMAS, C., HARRELL, F. E., JR., DESBIENS, N., FULKERSON, W. J., KUSSIN, P., BELLAMY, P., GOLDMAN, L. & KNAUS, W. A. 1996. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) [published erratum appears in Am J Respir Crit Care Med 1997;155:386]. Am J Respir Crit Care Med, 154, 959-67.
CORTEGIANI, A., LONGHINI, F., MADOTTO, F., GROFF, P., SCALA, R., CRIMI, C., CARLUCCI, A., BRUNI, A., GAROFALO, E., RAINERI, S. M., TONELLI, R., COMELLINI, V., LUPIA, E., VETRUGNO, L., CLINI, E., GIARRATANO, A., NAVA, S., NAVALESI, P. & GREGORETTI, C. 2020. High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial. Crit Care, 24, 692.
COTE, C., ZILBERBERG, M. D., MODY, S. H., DORDELLY, L. J. & CELLI, B. 2007a. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J, 29, 923-9.
COTE, C. G., PINTO-PLATA, V., KASPRZYK, K., DORDELLY, L. J. & CELLI, B. R. 2007b. The 6-min walk distance, peak oxygen uptake, and mortality in COPD. Chest, 132, 1778-85.
COTTIN, V. 2017. Combined pulmonary fibrosis and emphysema: bad and ugly all the same? Eur Respir J, 50.
COTTIN, V., SELMAN, M., INOUE, Y., WONG, A. W., CORTE, T. J., FLAHERTY, K. R., HAN, M. K., JACOB, J., JOHANNSON, K. A., KITAICHI, M., LEE, J. S., AGUSTI, A., ANTONIOU, K. M., BIANCHI, P., CARO, F., FLORENZANO, M., GALVIN, L., IWASAWA, T., MARTINEZ, F. J., MORGAN, R. L., MYERS, J. L., NICHOLSON, A. G., OCCHIPINTI, M., POLETTI, V., SALISBURY, M. L., SIN, D. D., SVERZELLATI, N., TONIA, T., VALENZUELA, C., RYERSON, C. J. & WELLS, A. U. 2022. Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement. Am J Respir Crit Care Med, 206, e7-e41. 
COURTNEY, R. J., MCROBBIE, H., TUTKA, P., WEAVER, N. A., PETRIE, D., MENDELSOHN, C. P., SHAKESHAFT, A., TALUKDER, S., MACDONALD, C., THOMAS, D., KWAN, B. C. H., WALKER, N., GARTNER, C., MATTICK, R. P., PAUL, C., FERGUSON, S. G., ZWAR, N. A., RICHMOND, R. L., DORAN, C. M., BOLAND, V. C., HALL, W., WEST, R. & FARRELL, M. 2021. Effect of Cytisine vs Varenicline on Smoking Cessation: A Randomized Clinical Trial. JAMA, 326, 56-64.
COUTURAUD, F., BERTOLETTI, L., PASTRE, J., ROY, P. M., LE MAO, R., GAGNADOUX, F., PALEIRON, N., SCHMIDT, J., SANCHEZ, O., DE MAGALHAES, E., KAMARA, M., HOFFMANN, C., BRESSOLLETTE, L., NONENT, M., TROMEUR, C., SALAUN, P. Y., BARILLOT, S., GATINEAU, F., MISMETTI, P., GIRARD, P., LACUT, K., LEMARIÉ, C. A., MEYER, G. & LEROYER, C. 2021. Prevalence of Pulmonary Embolism Among Patients With COPD Hospitalized With Acutely Worsening Respiratory Symptoms. Jama, 325, 59-68.
COVENTRY, P. A., BOWER, P., KEYWORTH, C., KENNING, C., KNOPP, J., GARRETT, C., HIND, D., MALPASS, A. & DICKENS, C. 2013. The effect of complex interventions on depression and anxiety in chronic obstructive pulmonary disease: systematic review and meta-analysis. PLoS One, 8, e60532.
COX, N. S., DAL CORSO, S., HANSEN, H., MCDONALD, C. F., HILL, C. J., ZANABONI, P., ALISON, J. A., O’HALLORAN, P., MACDONALD, H. & HOLLAND, A. E. 2021. Telerehabilitation for chronic respiratory disease. Cochrane Database Syst Rev, 1, Cd013040.
COX, N. S., MCDONALD, C. F., MAHAL, A., ALISON, J. A., WOOTTON, R., HILL, C. J., ZANABONI, P., O’HALLORAN, P., BONDARENKO, J., MACDONALD, H., BARKER, K., CRUTE, H., MELLERICK, C., WAGECK, B., BOURSINOS, H., LAHHAM, A., NICHOLS, A., CZUPRYN, P., CORBETT, M., HANDLEY, E., BURGE, A. T. & HOLLAND, A. E. 2022. Telerehabilitation for chronic respiratory disease: a randomised controlled equivalence trial. Thorax, 77, 643-651. 
CRAWFORD, G. B., BROOKSBANK, M. A., BROWN, M., BURGESS, T. A. & YOUNG, M. 2013. Unmet needs of people with end-stage chronic obstructive pulmonary disease: recommendations for change in Australia. Intern Med J, 43, 183-90.
CRESTANI, B., HUGGINS, J. T., KAYE, M., COSTABEL, U., GLASPOLE, I., OGURA, T., SONG, J. W., STANSEN, W., QUARESMA, M., STOWASSER, S. & KREUTER, M. 2019. Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON. Lancet Respir Med, 7, 60-68.
CREWS, W. D., JEFFERSON, A. L., BOLDUC, T., ELLIOTT, J. B., FERRO, N. M., BROSHEK, D. K., BARTH, J. T. & ROBBINS, M. K. 2001. Neuropsychological dysfunction in patients suffering from end-stage chronic obstructive pulmonary disease. Arch Clin Neuropsychol, 16, 643-52.
CRIM, C., CALVERLEY, P. M. A., ANDERSON, J. A., HOLMES, A. P., KILBRIDE, S., MARTINEZ, F. J., BROOK, R. D., NEWBY, D. E., YATES, J. C., CELLI, B. R. & VESTBO, J. 2017. Pneumonia risk with inhaled fluticasone furoate and vilanterol in COPD patients with moderate airflow limitation: The SUMMIT trial. Respir Med, 131, 27-34.
CRIM, C., DRANSFIELD, M. T., BOURBEAU, J., JONES, P. W., HANANIA, N. A., MAHLER, D. A., VESTBO, J., WACHTEL, A., MARTINEZ, F. J., BARNHART, F., LETTIS, S. & CALVERLEY, P. M. 2015. Pneumonia risk with inhaled fluticasone furoate and vilanterol compared with vilanterol alone in patients with COPD. Ann Am Thorac Soc, 12, 27-34.
CRINER, G. J., CELLI, B. R., BRIGHTLING, C. E., AGUSTI, A., PAPI, A., SINGH, D., SIN, D. D., VOGELMEIER, C. F., SCIURBA, F. C., BAFADHEL, M., BACKER, V., KATO, M., RAMIREZ-VENEGAS, A., WEI, Y. F., BJERMER, L., SHIH, V. H., JISON, M., O’QUINN, S., MAKULOVA, N., NEWBOLD, P., GOLDMAN, M. & MARTIN, U. J. 2019a. Benralizumab for the Prevention of COPD Exacerbations. N Engl J Med, 381, 1023-1034.
CRINER, G. J., CELLI, B. R., SINGH, D., AGUSTI, A., PAPI, A., JISON, M., MAKULOVA, N., SHIH, V. H., BROOKS, L., BARKER, P., MARTIN, U. J. & NEWBOLD, P. 2019b. Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies. Lancet Respir Med. Epub 2019 Sep 28.
CRINER, G. J., CONNETT, J. E., AARON, S. D., ALBERT, R. K., BAILEY, W. C., CASABURI, R., COOPER, J. A., JR., CURTIS, J. L., DRANSFIELD, M. T., HAN, M. K., MAKE, B., MARCHETTI, N., MARTINEZ, F. J., NIEWOEHNER, D. E., SCANLON, P. D., SCIURBA, F. C., SCHARF, S. M., SIN, D. D., VOELKER, H., WASHKO, G. R., WOODRUFF, P. G. & LAZARUS, S. C. 2014. Simvastatin for the prevention of exacerbations in moderate-to-severe COPD. N Engl J Med, 370, 2201-10.
CRINER, G. J., SUE, R., WRIGHT, S., DRANSFIELD, M., RIVAS-PEREZ, H., WIESE, T., SCIURBA, F. C., SHAH, P. L., WAHIDI, M. M., DE OLIVEIRA, H. G., MORRISSEY, B., CARDOSO, P. F. G., HAYS, S., MAJID, A., PASTIS, N., JR., KOPAS, L., VOLLENWEIDER, M., MCFADDEN, P. M., MACHUZAK, M., HSIA, D. W., SUNG, A., JARAD, N., KORNASZEWSKA, M., HAZELRIGG, S., KRISHNA, G., ARMSTRONG, B., SHARGILL, N. S., SLEBOS, D. J. & GROUP, L. S. 2018. A Multicenter RCT of Zephyr(R) Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE). Am J Respir Crit Care Med, 198,1151-1164.
CUI, H., WEI, Z. M., FAN, L., ZHANG, M., LIU, L. & HU, Y. X. 2012. [Clinical predictive value of hemoglobin level in mortality of hospitalized COPD patients]. Zhongguo Ying Yong Sheng Li Xue Za Zhi, 28, 394-7.
CUI, L., GALLAGHER, L. G., RAY, R. M., LI, W., GAO, D., ZHANG, Y., VEDAL, S., THOMAS, D. B. & CHECKOWAY, H. 2011. Unexpected excessive chronic obstructive pulmonary disease mortality among female silk textile workers in Shanghai, China. Occup Environ Med, 68, 883-7.
CURROW, D. C., MCDONALD, C., OATEN, S., KENNY, B., ALLCROFT, P., FRITH, P., BRIFFA, M., JOHNSON, M. J. & ABERNETHY, A. P. 2011. Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study. J Pain Symptom Manage, 42, 388-99.
D’URZO, A., FERGUSON, G. T., VAN NOORD, J. A., HIRATA, K., MARTIN, C., HORTON, R., LU, Y., BANERJI, D. & OVEREND, T. 2011. Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial. Respir Res, 12, 156.
D’URZO, A. D., RENNARD, S. I., KERWIN, E. M., MERGEL, V., LESELBAUM, A. R., CARACTA, C. F. & INVESTIGATORS, A. C. S. 2014. Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study. Respir Res, 15, 123.
DAGA, M. K., CHHABRA, R., SHARMA, B. & MISHRA, T. K. 2003. Effects of exogenous vitamin E supplementation on the levels of oxidants and antioxidants in chronic obstructive pulmonary disease. J Biosci, 28, 7-11.
DAHL, R., CHAPMAN, K. R., RUDOLF, M., MEHTA, R., KHO, P., ALAGAPPAN, V. K., CHEN, H. & BANERJI, D. 2013. Safety and efficacy of dual bronchodilation with QVA149 in COPD patients: the ENLIGHTEN study. Respir Med, 107, 1558-67.
DAL NEGRO, R. W., AQUILANI, R., BERTACCO, S., BOSCHI, F., MICHELETTO, C. & TOGNELLA, S. 2010. Comprehensive effects of supplemented essential amino acids in patients with severe COPD and sarcopenia. Monaldi Arch Chest Dis, 73, 25-33.
DANIELS, J. M., SNIJDERS, D., DE GRAAFF, C. S., VLASPOLDER, F., JANSEN, H. M. & BOERSMA, W. G. 2010. Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 181, 150-7.
DE KEYSER, H., VUONG, V., KAYE, L., ANDERSON, W. C., 3RD, SZEFLER, S. & STEMPEL, D. A. 2023. Is Once Versus Twice Daily Dosing Better for Adherence in Asthma and Chronic Obstructive Pulmonary Disease? J Allergy Clin Immunol Pract, 2087-2093.e3
DE LIMA, F. F., CAVALHERI, V., SILVA, B. S. A., GRIGOLETTO, I., UZELOTO, J. S., RAMOS, D., CAMILLO, C. A. & RAMOS, E. M. C. 2020. Elastic Resistance Training Produces Benefits Equivalent to Conventional Resistance Training in People With Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-Analysis. Phys Ther, 11, 1891-1905.
DE MATTEIS, S., JARVIS, D., DARNTON, A., HUTCHINGS, S., SADHRA, S., FISHWICK, D., RUSHTON, L. & CULLINAN, P. 2019. The occupations at increased risk of chronic obstructive pulmonary disease (COPD): analysis of lifetime job-histories in the population-based UK Biobank Cohort. Eur Respir J, 54(1),
DE MATTEIS, S., JARVIS, D., DARNTON, L., CONSONNI, D., KROMHOUT, H., HUTCHINGS, S., SADHRA, S. S., FISHWICK, D., VERMEULEN, R., RUSHTON, L. & CULLINAN, P. 2022. Lifetime occupational exposures and chronic obstructive pulmonary disease risk in the UK Biobank cohort. Thorax,77,  997-1005.
DE MIGUEL-DIEZ, J., CARRASCO-GARRIDO, P., REJAS-GUTIERREZ, J., MARTIN-CENTENO, A., GOBARTT-VAZQUEZ, E., HERNANDEZ-BARRERA, V., DE MIGUEL, A. G. & JIMENEZ-GARCIA, R. 2010. The influence of heart disease on characteristics, quality of life, use of health resources, and costs of COPD in primary care settings. <em, BMC Cardiovasc Disord,</em, 10<strong, ,</strong, 8.</td
DE SERRES, F. J. 2002. Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys. Chest, 122, 1818-29.
DE TORRES, J. P., MARIN, J. M., CASANOVA, C., COTE, C., CARRIZO, S., CORDOBA-LANUS, E., BAZ-DAVILA, R., ZULUETA, J. J., AGUIRRE-JAIME, A., SAETTA, M., COSIO, M. G. & CELLI, B. R. 2011. Lung cancer in patients with chronic obstructive pulmonary disease– incidence and predicting factors. Am J Respir Crit Care Med, 184, 913-9.
DECRAMER, M., CELLI, B., KESTEN, S., LYSTIG, T., MEHRA, S. & TASHKIN, D. P. 2009. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet, 374, 1171-8.
DECRAMER, M., DE BOCK, V. & DOM, R. 1996. Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 153, 1958-64.
DECRAMER, M., LACQUET, L. M., FAGARD, R. & ROGIERS, P. 1994. Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med, 150, 11-6.
DECRAMER, M. & STAS, K. J. 1992. Corticosteroid-induced myopathy involving respiratory muscles in patients with chronic obstructive pulmonary disease or asthma. Am Rev Respir Dis, 146, 800-2.
DECRAMER, M. L., CHAPMAN, K. R., DAHL, R., FRITH, P., DEVOUASSOUX, G., FRITSCHER, C., CAMERON, R., SHOAIB, M., LAWRENCE, D., YOUNG, D., MCBRYAN, D. & INVESTIGATORS, I. 2013. Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study. Lancet Respir Med, 1, 524-33.
DEMEO, D. L., RAMAGOPALAN, S., KAVATI, A., VEGESNA, A., HAN, M. K., YADAO, A., WILCOX, T. K. & MAKE, B. J. 2018. Women manifest more severe COPD symptoms across the life course. Int J Chron Obstruct Pulmon Dis, 13, 3021-3029.
DEMICHELI, V., JEFFERSON, T., DI PIETRANTONJ, C., FERRONI, E., THORNING, S., THOMAS, R. E. & RIVETTI, A. 2018. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev, 2, CD004876.
DEN HARDER, A. M., SNOEK, A. M., LEINER, T., SUYKER, W. J., DE HEER, L. M., BUDDE, R. P. J., LAMMERS, J. W. J., DE JONG, P. A. & GONDRIE, M. J. A. 2017. Can routine chest radiography be used to diagnose mild COPD? A nested case-control study. Eur J Radiol, 92, 159-165.
DEVEREUX, G., COTTON, S., FIELDING, S., MCMEEKIN, N., BARNES, P. J., BRIGGS, A., BURNS, G., CHAUDHURI, R., CHRYSTYN, H., DAVIES, L., DE SOYZA, A., GOMPERTZ, S., HAUGHNEY, J., INNES, K., KANIEWSKA, J., LEE, A., MORICE, A., NORRIE, J., SULLIVAN, A., WILSON, A. & PRICE, D. 2018. Effect of Theophylline as Adjunct to Inhaled Corticosteroids on Exacerbations in Patients With COPD: A Randomized Clinical Trial. Jama, 320, 1548-1559.
DHARMAGE, S. C., BUI, D. S., WALTERS, E. H., LOWE, A. J., THOMPSON, B., BOWATTE, G., THOMAS, P., GARCIA-AYMERICH, J., JARVIS, D., HAMILTON, G. S., JOHNS, D. P., FRITH, P., SENARATNA, C. V., IDROSE, N. S., WOOD-BAKER, R. R., HOPPER, J., GURRIN, L., ERBAS, B., WASHKO, G. R., FANER, R., AGUSTI, A., ABRAMSON, M. J., LODGE, C. J. & PERRET, J. L. 2023. Lifetime spirometry patterns of obstruction and restriction, and their risk factors and outcomes: a prospective cohort study. Lancet Respir Med, 11, 273-282.
DIAZ, A. A., OREJAS, J. L., GRUMLEY, S., NATH, H. P., WANG, W., DOLLIVER, W. R., YEN, A., KLIGERMAN, S. J., JACOBS, K., MANAPRAGADA, P. P., ABOZEED, M., AZIZ, M. U., ZAHID, M., AHMED, A. N., TERRY, N. L., SAN JOSÉ ESTÉPAR, R., KIM, V., MAKE, B. J., HAN, M. K., SONAVANE, S., WASHKO, G. R., CHO, M. & SAN JOSÉ ESTÉPAR, R. 2023. Airway-Occluding Mucus Plugs and Mortality in Patients With Chronic Obstructive Pulmonary Disease. Jama, 329, 1832-1839.
DIAZ-FUENTES, G., HASHMI, H. R. & VENKATRAM, S. 2016. Perioperative Evaluation of Patients with Pulmonary Conditions Undergoing Non-Cardiothoracic Surgery. Health Serv Insights, 9, 9-23.
DIAZ-GUZMAN, E., ARYAL, S. & MANNINO, D. M. 2012. Occupational chronic obstructive pulmonary disease: an update. Clin Chest Med, 33, 625-36.
DICKENS, C., KATON, W., BLAKEMORE, A., KHARA, A., TOMENSON, B., WOODCOCK, A., FRYER, A. & GUTHRIE, E. 2014. Complex interventions that reduce urgent care use in COPD: a systematic review with meta-regression. Respir Med, 108, 426-37.
DIJK, W. D., BEMT, L., HAAK-RONGEN, S., BISCHOFF, E., WEEL, C., VEEN, J. C. & SCHERMER, T. R. 2011. Multidimensional prognostic indices for use in COPD patient care. A systematic review. Respir Res, 12, 151.
DISANTOSTEFANO, R. L., LI, H., HINDS, D., GALKIN, D. V. & RUBIN, D. B. 2014. Risk of pneumonia with inhaled corticosteroid/long-acting beta2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis. Int J Chron Obstruct Pulmon Dis, 9, 457-68.
DIVO, M. J., CELLI, B. R., POBLADOR-PLOU, B., CALDERON-LARRANAGA, A., DE-TORRES, J. P., GIMENO-FELIU, L. A., BERTO, J., ZULUETA, J. J., CASANOVA, C., PINTO-PLATA, V. M., CABRERA-LOPEZ, C., POLVERINO, F., CARMONA PIREZ, J., PRADOS-TORRES, A. & MARIN, J. M. 2018. Chronic Obstructive Pulmonary Disease (COPD) as a disease of early aging: Evidence from the EpiChron Cohort. PLoS One, 13, e0193143.
DODD, J. W., CHARLTON, R. A., VAN DEN BROEK, M. D. & JONES, P. W. 2013. Cognitive dysfunction in patients hospitalized with acute exacerbation of COPD. Chest, 144, 119-27.
DONAIRE-GONZALEZ, D., GIMENO-SANTOS, E., BALCELLS, E., DE BATLLE, J., RAMON, M. A., RODRIGUEZ, E., FARRERO, E., BENET, M., GUERRA, S., SAULEDA, J., FERRER, A., FERRER, J., BARBERA, J. A., RODRIGUEZ-ROISIN, R., GEA, J., AGUSTI, A., ANTO, J. M., GARCIA-AYMERICH, J. & GROUP, P.-C. S. 2015. Benefits of physical activity on COPD hospitalisation depend on intensity. Eur Respir J, 46, 1281-9.
DONALDSON, G. C., HURST, J. R., SMITH, C. J., HUBBARD, R. B. & WEDZICHA, J. A. 2010. Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest, 137, 1091-7.
DONG, Y. H., CHANG, C. H., LIN WU, F. L., SHEN, L. J., CALVERLEY, P. M., LOFDAHL, C. G., LAI, M. S. & MAHLER, D. A. 2014. Use of inhaled corticosteroids in patients with COPD and the risk of TB and influenza: A systematic review and meta-analysis of randomized controlled trials. a systematic review and meta-analysis of randomized controlled trials. Chest, 145, 1286-97.
DONOHUE, J. F., FOGARTY, C., LOTVALL, J., MAHLER, D. A., WORTH, H., YORGANCIOGLU, A., IQBAL, A., SWALES, J., OWEN, R., HIGGINS, M. & KRAMER, B. 2010. Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium. Am J Respir Crit Care Med, 182, 155-62.
DONOHUE, J. F., MALEKI-YAZDI, M. R., KILBRIDE, S., MEHTA, R., KALBERG, C. & CHURCH, A. 2013. Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD. Respir Med, 107, 1538-46.
DONOHUE, J. F., NIEWOEHNER, D., BROOKS, J., O’DELL, D. & CHURCH, A. 2014. Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results from a 52-week, randomized, double-blind, placebo-controlled study. Respir Res, 15, 78.
DONOVAN, T., MILAN, S. J., WANG, R., BANCHOFF, E., BRADLEY, P. & CROSSINGHAM, I. 2020. Anti-IL-5 therapies for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 12, Cd013432.
DOWSON, C. A., TOWN, G. I., FRAMPTON, C. & MULDER, R. T. 2004. Psychopathology and illness beliefs influence COPD self-management. J Psychosom Res, 56, 333-40.
DOYLE, C., BHAR, S., FEARN, M., AMES, D., OSBORNE, D., YOU, E., GORELIK, A. & DUNT, D. 2017. The impact of telephone-delivered cognitive behaviour therapy and befriending on mood disorders in people with chronic obstructive pulmonary disease: A randomized controlled trial. Br J Health Psychol, 22, 542-556.
DRANSFIELD, M. T., BOURBEAU, J., JONES, P. W., HANANIA, N. A., MAHLER, D. A., VESTBO, J., WACHTEL, A., MARTINEZ, F. J., BARNHART, F., SANFORD, L., LETTIS, S., CRIM, C. & CALVERLEY, P. M. 2013. Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials. Lancet Respir Med, 1, 210-23.
DRANSFIELD, M. T., FELDMAN, G., KORENBLAT, P., LAFORCE, C. F., LOCANTORE, N., PISTOLESI, M., WATKINS, M. L., CRIM, C. & MARTINEZ, F. J. 2014. Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients. Respir Med, 108, 1171-9.
DRANSFIELD, M. T., KUNISAKI, K. M., STRAND, M. J., ANZUETO, A., BHATT, S. P., BOWLER, R. P., CRINER, G. J., CURTIS, J. L., HANANIA, N. A., NATH, H., PUTCHA, N., ROARK, S. E., WAN, E. S., WASHKO, G. R., WELLS, J. M., WENDT, C. H. & MAKE, B. J. 2017. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med, 195, 324-330.
DRANSFIELD, M. T., MCALLISTER, D. A., ANDERSON, J. A., BROOK, R. D., CALVERLEY, P. M. A., CELLI, B. R., CRIM, C., GALLOT, N., MARTINEZ, F. J., SCANLON, P. D., YATES, J., VESTBO, J. & NEWBY, D. E. 2018. beta-Blocker Therapy and Clinical Outcomes in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk. An Observational Substudy of SUMMIT. Ann Am Thorac Soc, 15, 608-614.
DRANSFIELD, M. T., VOELKER, H., BHATT, S. P., BRENNER, K., CASABURI, R., COME, C. E., COOPER, J. A. D., CRINER, G. J., CURTIS, J. L., HAN, M. K., HATIPOGLU, U., HELGESON, E. S., JAIN, V. V., KALHAN, R., KAMINSKY, D., KANER, R., KUNISAKI, K. M., LAMBERT, A. A., LAMMI, M. R., LINDBERG, S., MAKE, B. J., MARTINEZ, F. J., MCEVOY, C., PANOS, R. J., REED, R. M., SCANLON, P. D., SCIURBA, F. C., SMITH, A., SRIRAM, P. S., STRINGER, W. W., WEINGARTEN, J. A., WELLS, J. M., WESTFALL, E., LAZARUS, S. C. & CONNETT, J. E. 2019. Metoprolol for the Prevention of Acute Exacerbations of COPD. N Engl J Med. 381(24), 2304-2314.
DU, Q., JIN, J., LIU, X. & SUN, Y. 2016. Bronchiectasis as a Comorbidity of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. PLoS One, 11, e0150532.
DUCKWORTH, C., BONIFACE, M. J., KIRK, A. & WILKINSON, T. M. A. 2023. Exploring the Validity of GOLD 2023 Guidelines: Should GOLD C and D Be Combined? Int J Chron Obstruct Pulmon Dis, 18, 2335-2339.
DUMMER, J., DOBLER, C. C., HOLMES, M., CHAMBERS, D., YANG, I. A., PARKIN, L., SMITH, S., WARK, P., DEV, A., HODGE, S., DABSCHECK, E., GOOI, J., SAMUEL, S., KNOWLES, S. & HOLLAND, A. E. 2020. Diagnosis and treatment of lung disease associated with alpha one-antitrypsin deficiency: A position statement from the Thoracic Society of Australia and New Zealand. Respirology, 25, 321-335.
DUNSTAN, D. W., BARR, E. L., HEALY, G. N., SALMON, J., SHAW, J. E., BALKAU, B., MAGLIANO, D. J., CAMERON, A. J., ZIMMET, P. Z. & OWEN, N. 2010. Television viewing time and mortality: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Circulation, 121, 384-91.
EATON, T., LEWIS, C., YOUNG, P., KENNEDY, Y., GARRETT, J. E. & KOLBE, J. 2004. Long-term oxygen therapy improves health-related quality of life. Respir Med, 98, 285-93.
ECHEVARRIA, C., STEER, J. & BOURKE, S. C. 2019. Comparison of early warning scores in patients with COPD exacerbation: DECAF and NEWS score. Thorax, 74, 941-946.
ECHEVARRIA, C., STEER, J., WASON, J. & BOURKE, S. 2020. Oxygen therapy and inpatient mortality in COPD exacerbation. Emerg Med J.
EDUARD, W., PEARCE, N. & DOUWES, J. 2009. Chronic bronchitis, COPD, and lung function in farmers: the role of biological agents. Chest, 136, 716-25.
EISNER, M. D., ANTHONISEN, N., COULTAS, D., KUENZLI, N., PEREZ-PADILLA, R., POSTMA, D., ROMIEU, I., SILVERMAN, E. K. & BALMES, J. R. 2010a. An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 182, 693-718.
EISNER, M. D., BLANC, P. D., YELIN, E. H., KATZ, P. P., SANCHEZ, G., IRIBARREN, C. & OMACHI, T. A. 2010b. Influence of anxiety on health outcomes in COPD. Thorax, 65, 229-34.
EKPU, V. U. & BROWN, A. K. 2015. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence. Tob Use Insights, 8, 1-35.
EKSTROM, M., BORNEFALK-HERMANSSON, A., ABERNETHY, A. & CURROW, D. 2015a. Low-dose opioids should be considered for symptom relief also in advanced chronic obstructive pulmonary disease (COPD). Evid Based Med, 20, 39.
EKSTROM, M., FRANKLIN, K. A. & STROM, K. E. 2010. Increased relative mortality in women with severe oxygen-dependent COPD. Chest, 137, 31-6.
EKSTROM, M., NILSSON, F., ABERNETHY, A. A. & CURROW, D. C. 2015b. Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review. Ann Am Thorac Soc, 12, 1079-92.
EKSTROM, M. P., BORNEFALK-HERMANSSON, A., ABERNETHY, A. P. & CURROW, D. C. 2014. Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study. BMJ, 348, g445.
EL MOUSSAOUI, R., ROEDE, B. M., SPEELMAN, P., BRESSER, P., PRINS, J. M. & BOSSUYT, P. M. 2008. Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies. Thorax, 63, 415-22.
ELBEHAIRY, A. F., GUENETTE, J. A., FAISAL, A., CIAVAGLIA, C. E., WEBB, K. A., JENSEN, D., RAMSOOK, A. H., NEDER, J. A., O’DONNELL, D. E. & CANADIAN RESPIRATORY RESEARCH, N. 2016. Mechanisms of exertional dyspnoea in symptomatic smokers without COPD. Eur Respir J, 48, 694-705.
EMTNER, M., PORSZASZ, J., BURNS, M., SOMFAY, A. & CASABURI, R. 2003. Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. Am J Respir Crit Care Med, 168, 1034-42.
EPSTEIN, D., BARAK-CORREN, Y., ISENBERG, Y. & BERGER, G. 2019. Clinical Decision Support System: A Pragmatic Tool to Improve Acute Exacerbation of COPD Discharge Recommendations. Copd, 1-7.
ERNST, P., GONZALEZ, A. V., BRASSARD, P. & SUISSA, S. 2007. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Am J Respir Crit Care Med, 176, 162-6.
ESTEBAN, A., ANZUETO, A., ALIA, I., GORDO, F., APEZTEGUIA, C., PALIZAS, F., CIDE, D., GOLDWASER, R., SOTO, L., BUGEDO, G., RODRIGO, C., PIMENTEL, J., RAIMONDI, G. & TOBIN, M. J. 2000. How is mechanical ventilation employed in the intensive care unit? An international utilization review. Am J Respir Crit Care Med, 161, 1450-8.
ESTEBAN, C., QUINTANA, J. M., EGURROLA, M., MORAZA, J., ABURTO, M., PEREZ-IZQUIERDO, J., BASUALDO, L. V. & CAPELASTEGUI, A. 2009. Classifying the severity of COPD: are the new severity scales better than the old? Int J Tuberc Lung Dis, 13, 783-90.
EURICH, D. T., SADOWSKI, C. A., SIMPSON, S. H., MARRIE, T. J. & MAJUMDAR, S. R. 2010. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs. Am J Med, 123, 47-53.
EVANS, R. A., SINGH, S. J., COLLIER, R., WILLIAMS, J. E. & MORGAN, M. D. 2009. Pulmonary rehabilitation is successful for COPD irrespective of MRC dyspnoea grade. Respir Med, 103, 1070-5.
FAES, K., COHEN, J. & ANNEMANS, L. 2018. Resource Use During the Last Six Months of Life Among COPD Patients: A Population-Level Study. J Pain Symptom Manage, 56, 318-326 e7.
FALAGAS, M. E., AVGERI, S. G., MATTHAIOU, D. K., DIMOPOULOS, G. & SIEMPOS, II 2008. Short- versus long-duration antimicrobial treatment for exacerbations of chronic bronchitis: a meta-analysis. J Antimicrob Chemother, 62, 442-50.
FAN, V. S., GAZIANO, J. M., LEW, R., BOURBEAU, J., ADAMS, S. G., LEATHERMAN, S., THWIN, S. S., HUANG, G. D., ROBBINS, R., SRIRAM, P. S., SHARAFKHANEH, A., MADOR, M. J., SAROSI, G., PANOS, R. J., RASTOGI, P., WAGNER, T. H., MAZZUCA, S. A., SHANNON, C., COLLING, C., LIANG, M. H., STOLLER, J. K., FIORE, L. & NIEWOEHNER, D. E. 2012. A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. Ann Intern Med, 156, 673-83.
FAN, S., ZHANG, Z. & WANG, Q. 2023. Efficacy of acupuncture therapy for stable chronic obstructive pulmonary disease: A systematic review and meta-analysis. Medicine (Baltimore), 102, e33537.
FANNING, M., MCKEAN, M., SEYMOUR, K., PILLANS, P. & SCOTT, I. 2014. Adherence to guideline-based antibiotic treatment for acute exacerbations of chronic obstructive pulmonary disease in an Australian tertiary hospital. Intern Med J, 44, 903-10.
FARVER-VESTERGAARD, I., JACOBSEN, D. & ZACHARIAE, R. 2015. Efficacy of psychosocial interventions on psychological and physical health outcomes in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Psychother Psychosom, 84, 37-50.
FARVER-VESTERGAARD, I., O’TOOLE, M. S., O’CONNOR, M., LOKKE, A., BENDSTRUP, E., BASDEO, S. A., COX, D. J., DUNNE, P. J., RUGGERI, K., EARLY, F. & ZACHARIAE, R. 2018. Mindfulness-based cognitive therapy in COPD: a cluster randomised controlled trial. Eur Respir J, 51.
FATHIMA, M., NAIK-PANVELKAR, P., SAINI, B. & ARMOUR, C. L. 2013. The role of community pharmacists in screening and subsequent management of chronic respiratory diseases: a systematic review. Pharm Pract (Granada), 11, 228-45.
FEARY, J. R., RODRIGUES, L. C., SMITH, C. J., HUBBARD, R. B. & GIBSON, J. E. 2010. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax, 65, 956-62.
FELDMAN, G., MALTAIS, F., KHINDRI, S., VAHDATI-BOLOURI, M., CHURCH, A., FAHY, W. A. & TRIVEDI, R. 2016. A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 mug compared with tiotropium 18 mug in patients with COPD. Int J Chron Obstruct Pulmon Dis, 11, 719-30.
FENG, J., WANG, X., LI, X., ZHAO, D. & XU, J. 2016. Acupuncture for chronic obstructive pulmonary disease (COPD): A multicenter, randomized, sham-controlled trial. Medicine (Baltimore), 95, e4879.
FERGUSON, G. T., CALVERLEY, P. M., ANDERSON, J. A., JENKINS, C. R., JONES, P. W., WILLITS, L. R., YATES, J. C., VESTBO, J. & CELLI, B. 2009. Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study. Chest, 136, 1456-65.
FERGUSON, G. T., RABE, K. F., MARTINEZ, F. J., FABBRI, L. M., WANG, C., ICHINOSE, M., BOURNE, E., BALLAL, S., DARKEN, P., DEANGELIS, K., AURIVILLIUS, M., DORINSKY, P. & REISNER, C. 2018. Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial. Lancet Respir Med, 6, 747-758.
FERGUSON, G. T., TASHKIN, D. P., SKARBY, T., JORUP, C., SANDIN, K., GREENWOOD, M., PEMBERTON, K. & TRUDO, F. 2017. Effect of budesonide/formoterol pressurized metered-dose inhaler on exacerbations versus formoterol in chronic obstructive pulmonary disease: The 6-month, randomized RISE (Revealing the Impact of Symbicort in reducing Exacerbations in COPD) study. Respir Med, 132, 31-41.
FERREIRA, I. M., BROOKS, D., WHITE, J. & GOLDSTEIN, R. 2012. Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 12, CD000998.
FERRONE, M., MASCIANTONIO, M. G., MALUS, N., STITT, L., O’CALLAHAN, T., ROBERTS, Z., JOHNSON, L., SAMSON, J., DUROCHER, L., FERRARI, M., REILLY, M., GRIFFITHS, K. & LICSKAI, C. J. 2019. The impact of integrated disease management in high-risk COPD patients in primary care. NPJ Prim Care Respir Med, 29, 8.
FIELDS, A. C. & DIVINO, C. M. 2016. Surgical outcomes in patients with chronic obstructive pulmonary disease undergoing abdominal operations: An analysis of 331,425 patients. Surgery, 159, 1210-1216.
FISHMAN, A., MARTINEZ, F., NAUNHEIM, K., PIANTADOSI, S., WISE, R., RIES, A., WEINMANN, G. & WOOD, D. E. 2003. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med, 348, 2059-73.
FITZGERALD, J. M. 2011. Targeting lung attacks. Thorax, 66, 365-6.
FLETCHER, E. C., LUCKETT, R. A., GOODNIGHT-WHITE, S., MILLER, C. C., QIAN, W. & COSTARANGOS-GALARZA, C. 1992. A double-blind trial of nocturnal supplemental oxygen for sleep desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mm Hg. Am Rev Respir Dis, 145, 1070-6.
FLETCHER, C. & PETO, R. 1977. The natural history of chronic airflow obstruction. Br Med J, 1, 1645-8.
FLETCHER, C. M., CLIFTON M., FAIRBAIRN AS., FRY J., GILSON JC., HIGGINS ITT., MAIR A., PEMBERTON J., ROGAN JM., SMITH DH. & WOOD CH. 1960. Standardized questionnaires on respiratory symptoms. Br Med J, 2, 1665.
FRASER, A. & POOLE, P. 2022. Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 11, Cd013343.
FRASER, J. F., SPOONER, A. J., DUNSTER, K. R., ANSTEY, C. M. & CORLEY, A. 2016. Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial. Thorax, 71, 759-61.
FRAT, J. P., THILLE, A. W., MERCAT, A., GIRAULT, C., RAGOT, S., PERBET, S., PRAT, G., BOULAIN, T., MORAWIEC, E., COTTEREAU, A., DEVAQUET, J., NSEIR, S., RAZAZI, K., MIRA, J. P., ARGAUD, L., CHAKARIAN, J. C., RICARD, J. D., WITTEBOLE, X., CHEVALIER, S., HERBLAND, A., FARTOUKH, M., CONSTANTIN, J. M., TONNELIER, J. M., PIERROT, M., MATHONNET, A., BEDUNEAU, G., DELETAGE-METREAU, C., RICHARD, J. C., BROCHARD, L., ROBERT, R., GROUP, F. S. & NETWORK, R. 2015. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med, 372, 2185-96.
FREI, A., RADTKE, T., LANA, K. D., BRUN, P., SIGRIST, T., SPIELMANNS, M., BEYER, S., RIEGLER, T. F., BÜSCHING, G., SPIELMANNS, S., KUNZ, R., CERINI, T., BRAUN, J., TOMONAGA, Y., BURRIEL, M. S., POLHEMUS, A. & PUHAN, M. A. 2022. Effectiveness of a long-term home-based exercise training program in patients with COPD following pulmonary rehabilitation: A multicenter randomized controlled trial. Chest, 162, 1277-1286. 
FRIED, L. P., TANGEN, C. M., WALSTON, J., NEWMAN, A. B., HIRSCH, C., GOTTDIENER, J., SEEMAN, T., TRACY, R., KOP, W. J., BURKE, G., MCBURNIE, M. A. & CARDIOVASCULAR HEALTH STUDY COLLABORATIVE RESEARCH, G. 2001. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci, 56, M146-56.
FRITH, P. A., THOMPSON, P. J., RATNAVADIVEL, R., CHANG, C. L., BREMNER, P., DAY, P., FRENZEL, C. & KURSTJENS, N. 2015. Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study-a randomised controlled trial. Thorax, 70, 519-27.
FUKUDA, N., HORITA, N., KANEKO, A., GOTO, A., KANEKO, T., OTA, E. & KEW, K. M. 2023. Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 6, Cd012066.
FURLANETTO, K. C., DONARIA, L., SCHNEIDER, L. P., LOPES, J. R., RIBEIRO, M., FERNANDES, K. B., HERNANDES, N. A. & PITTA, F. 2017. Sedentary Behavior Is an Independent Predictor of Mortality in Subjects With COPD. Respir Care, 62, 579-587.
FURUMOTO, A., OHKUSA, Y., CHEN, M., KAWAKAMI, K., MASAKI, H., SUEYASU, Y., IWANAGA, T., AIZAWA, H., NAGATAKE, T. & OISHI, K. 2008. Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease. Vaccine, 26, 4284-9.
FUSCHILLO, S., MARTUCCI, M., DONNER, C. F. & BALZANO, G. 2012. Airway bacterial colonization: the missing link between COPD and cardiovascular events? Respir Med, 106, 915-23.
GALBRAITH, S., FAGAN, P., PERKINS, P., LYNCH, A. & BOOTH, S. 2010. Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. J Pain Symptom Manage, 39, 831-8.
GALE, N. S., ALBARRATI, A. M., MUNNERY, M. M., HUBBARD, R. E., TAL-SINGER, R., COCKCROFT, J. R. & SHALE, D. J. 2018. Frailty: A global measure of the multisystem impact of COPD. Chron Respir Dis, 15, 347-355.
GALIZIA, G., CACCIATORE, F., TESTA, G., DELLA-MORTE, D., MAZZELLA, F., LANGELLOTTO, A., RAUCCI, C., GARGIULO, G., FERRARA, N., RENGO, F. & ABETE, P. 2011. Role of clinical frailty on long-term mortality of elderly subjects with and without chronic obstructive pulmonary disease. Aging Clin Exp Res, 23, 118-25.
GAN, W. Q., MAN, S. F., POSTMA, D. S., CAMP, P. & SIN, D. D. 2006. Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res, 7, 52.
GARBER, C. E., BLISSMER, B., DESCHENES, M. R., FRANKLIN, B. A., LAMONTE, M. J., LEE, I. M., NIEMAN, D. C., SWAIN, D. P. & AMERICAN COLLEGE OF SPORTS, M. 2011. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc, 43, 1334-59.
GARCIA-AYMERICH, J., LANGE, P., BENET, M., SCHNOHR, P. & ANTO, J. M. 2006. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax, 61, 772-8.
GARCIA-AYMERICH, J., SERRA, I., GOMEZ, F. P., FARRERO, E., BALCELLS, E., RODRIGUEZ, D. A., DE BATLLE, J., GIMENO, E., DONAIRE-GONZALEZ, D., OROZCO-LEVI, M., SAULEDA, J., GEA, J., RODRIGUEZ-ROISIN, R., ROCA, J., AGUSTI, A. G. & ANTO, J. M. 2009. Physical activity and clinical and functional status in COPD. Chest, 136, 62-70.
GARCÍA-SANZ, M. T., CÁNIVE-GÓMEZ, J. C., SENÍN-RIAL, L., ABOAL-VIÑAS, J., BARREIRO-GARCÍA, A., LÓPEZ-VAL, E. & GONZÁLEZ-BARCALA, F. J. 2017. One-year and long-term mortality in patients hospitalized for chronic obstructive pulmonary disease. J Thorac Dis, 9, 636-645
GEAKE, J. B., DABSCHECK, E. J., WOOD-BAKER, R. & CATES, C. J. 2015. Indacaterol, a once-daily beta2-agonist, versus twice-daily beta(2)-agonists or placebo for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 1, CD010139.
GEELHOED, E. A., BRAMELD, K. J., HOLMAN, C. D. & THOMPSON, P. J. 2007. Readmission and survival following hospitalization for chronic obstructive pulmonary disease: long-term trends. Intern Med J, 37, 87-94.
GERBER, A., MOYNIHAN, C., KLIM, S., RITCHIE, P. & KELLY, A. M. 2018. Compliance with a COPD bundle of care in an Australian emergency department: A cohort study. Clin Respir J, 12 (2): 706-11.
GERSHON, A. S., MECREDY, G. C., GUAN, J., VICTOR, J. C., GOLDSTEIN, R. & TO, T. 2015. Quantifying comorbidity in individuals with COPD: a population study. Eur Respir J, 45, 51-9.
GHANNOUCHI, I., SPEYER, R., DOMA, K., CORDIER, R. & VERIN, E. 2016. Swallowing function and chronic respiratory diseases: Systematic review. Respir Med, 117, 54-64.
GIBSON, P. G. & MCDONALD, V. M. 2015. Asthma-COPD overlap 2015: now we are six. Thorax, 70, 683-91.
GILBERT, D. N. 2011. Procalcitonin as a biomarker in respiratory tract infection. Clin Infect Dis, 52 Suppl 4, S346-50.
GIMENO-SANTOS, E., FREI, A., STEURER-STEY, C., DE BATLLE, J., RABINOVICH, R. A., RASTE, Y., HOPKINSON, N. S., POLKEY, M. I., VAN REMOORTEL, H., TROOSTERS, T., KULICH, K., KARLSSON, N., PUHAN, M. A. & GARCIA-AYMERICH, J. 2014. Determinants and outcomes of physical activity in patients with COPD: a systematic review. Thorax, 69, 731-9.
GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE (GOLD). 2018. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2018 Report). GOLD.
GLOBAL INITIATIVE FOR ASTHMA. 2019. Global Strategy for Asthma Management and Prevention: 2019 Update.
GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE (GOLD). 2021. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2021 Report). GOLD.
GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE (GOLD). 2023. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2023 Report). GOLD.
GONZALEZ LINDH, M., BLOM JOHANSSON, M., JENNISCHE, M. & KOYI, H. 2017. Prevalence of swallowing dysfunction screened in Swedish cohort of COPD patients. Int J Chron Obstruct Pulmon Dis, 12, 331-337.
GOOD-FRATTURELLI, M. D., CURLEE, R. F. & HOLLE, J. L. 2000. Prevalence and nature of dysphagia in VA patients with COPD referred for videofluoroscopic swallow examination. J Commun Disord, 33, 93-110.
GORDON, C. S., WALLER, J. W., COOK, R. M., CAVALERA, S. L., LIM, W. T. & OSADNIK, C. R. 2019. Effect of Pulmonary Rehabilitation on Symptoms of Anxiety and Depression in COPD: A Systematic Review and Meta-Analysis. Chest, 156, 80-91.
GORECKA, D., GORZELAK, K., SLIWINSKI, P., TOBIASZ, M. & ZIELINSKI, J. 1997. Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax, 52, 674-9.
GOURLAY, S. G., STEAD, L. F. & BENOWITZ, N. L. 2004. Clonidine for smoking cessation. Cochrane Database Syst Rev, CD000058.
GRANT, I., HEATON, R. K., MCSWEENY, A. J., ADAMS, K. M. & TIMMS, R. M. 1982. Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med, 142, 1470-6.
GREGERSEN, T. L., GREEN, A., FRAUSING, E., RINGBAEK, T., BRONDUM, E. & SUPPLI ULRIK, C. 2016. Do telemedical interventions improve quality of life in patients with COPD? A systematic review. Int J Chron Obstruct Pulmon Dis, 11, 809-22.
GRIFFITHS, T. L., PHILLIPS, C. J., DAVIES, S., BURR, M. L. & CAMPBELL, I. A. 2001. Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme. Thorax, 56, 779-84.
GROSS, R. D., ATWOOD, C. W., JR., ROSS, S. B., OLSZEWSKI, J. W. & EICHHORN, K. A. 2009. The coordination of breathing and swallowing in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 179, 559-65.
GROSSMAN, J. M., GORDON, R., RANGANATH, V. K., DEAL, C., CAPLAN, L., CHEN, W., CURTIS, J. R., FURST, D. E., MCMAHON, M., PATKAR, N. M., VOLKMANN, E. & SAAG, K. G. 2010. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken), 62, 1515-26.
GUDMUNDSSON, G., GISLASON, T., JANSON, C., LINDBERG, E., HALLIN, R., ULRIK, C. S., BRONDUM, E., NIEMINEN, M. M., AINE, T. & BAKKE, P. 2005. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J, 26, 414-9.
GUERRA, S. 2009. Asthma and chronic obstructive pulmonary disease. Curr Opin Allergy Clin Immunol, 9, 409-16.
GUERRERO, M., CRISAFULLI, E., LIAPIKOU, A., HUERTA, A., GABARRUS, A., CHETTA, A., SOLER, N. & TORRES, A. 2016. Readmission for Acute Exacerbation within 30 Days of Discharge Is Associated with a Subsequent Progressive Increase in Mortality Risk in COPD Patients: A Long-Term Observational Study. PLoS One, 11, e0150737.
GUIRGUIS-BLAKE, J. M., SENGER, C. A., WEBBER, E. M., MULARSKI, R. A. & WHITLOCK, E. P. 2016. Screening for Chronic Obstructive Pulmonary Disease: Evidence Report and Systematic Review for the US Preventive Services Task Force. Jama, 315, 1378-93.
GULMEZ, S. E., HOLM, A., FREDERIKSEN, H., JENSEN, T. G., PEDERSEN, C. & HALLAS, J. 2007. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. Arch Intern Med, 167, 950-5.
GUO, J., WANG, C., CHAN, K. S., JIN, D., SAHA, P. K., SIEREN, J. P., BARR, R. G., HAN, M. K., KAZEROONI, E., COOPER, C. B., COUPER, D., NEWELL, J. D., JR. & HOFFMAN, E. A. 2016a. A controlled statistical study to assess measurement variability as a function of test object position and configuration for automated surveillance in a multicenter longitudinal COPD study (SPIROMICS). Med Phys, 43, 2598.<td/td>
GUO, R., PITTLER, M. H. & ERNST, E. 2006. Herbal medicines for the treatment of COPD: a systematic review. Eur Respir J, 28, 330-8.
GUO, Y., ZHANG, T., WANG, Z., YU, F., XU, Q., GUO, W., WU, C. & HE, J. 2016. Body mass index and mortality in chronic obstructive pulmonary disease: A dose-response meta-analysis. Medicine (Baltimore), 95, e4225.
GUPTA, D., AGARWAL, R., AGGARWAL, A. N., MATURU, V. N., DHOORIA, S., PRASAD, K. T., SEHGAL, I. S., YENGE, L. B., JINDAL, A., SINGH, N., GHOSHAL, A. G., KHILNANI, G. C., SAMARIA, J. K., GAUR, S. N., BEHERA, D. & JINDAL, S. K. 2014. Guidelines for diagnosis and management of chronic obstructive pulmonary disease: joint recommendations of Indian Chest Society and National College of Chest Physicians (India). Indian J Chest Dis Allied Sci, 56 Spec No, 5-54.
GUPTA, H., RAMANAN, B., GUPTA, P. K., FANG, X., POLICH, A., MODRYKAMIEN, A., SCHULLER, D. & MORROW, L. E. 2013. Impact of COPD on postoperative outcomes: results from a national database. Chest, 143, 1599-606.
GUYATT, G. H., OXMAN, A. D., VIST, G. E., KUNZ, R., FALCK-YTTER, Y., ALONSO-COELLO, P., SCHUNEMANN, H. J. & GROUP, G. W. 2008. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ, 336, 924-6.
GUYATT, G. H., TOWNSEND, M., PUGSLEY, S. O., KELLER, J. L., SHORT, H. D., TAYLOR, D. W. & NEWHOUSE, M. T. 1987. Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life. Am Rev Respir Dis, 135, 1069-74.
> 924-6.
GYSELS, M. & HIGGINSON, I. J. 2008. Access to services for patients with chronic obstructive pulmonary disease: the invisibility of breathlessness. J Pain Symptom Manage, 36, 451-60.